{
  "article_title": "Genome Scale CRISPR Cas9a Knockout Screen Reveals Genes That Control Glioblastoma Susceptibility to the Alkylating Agent Temozolomide",
  "dataset_filename": "downloads/awahGenomeScaleCRISPR2022_35990011_5953_DMSO_Day14_R2.txt",
  "sheet_name": "None",
  "dataset_type": "All genes/guides",
  "metrics": ["count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA sequences used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Count",
      "interpretation": "The count of each sgRNA in the dataset, representing the abundance of the corresponding gene."
    }
  ]
}
{
  "article_title": "Genome Scale CRISPR Cas9a Knockout Screen Reveals Genes That Control Glioblastoma Susceptibility to the Alkylating Agent Temozolomide",
  "dataset_filename": "downloads/awahGenomeScaleCRISPR2022_35990011_6396_Puromycin_Day0.txt",
  "sheet_name": "None",
  "dataset_type": "All genes/guides",
  "metrics": ["count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA sequences used in the CRISPR screen to target specific genes."
    },
    {
      "dataset_filename_table_name_column_name": "Count",
      "interpretation": "The count of each sgRNA in the dataset, representing the abundance of the corresponding gene."
    }
  ]
}
{
  "article_title": "Genome Scale CRISPR Cas9a Knockout Screen Reveals Genes That Control Glioblastoma Susceptibility to the Alkylating Agent Temozolomide",
  "dataset_filename": "downloads/awahGenomeScaleCRISPR2022_35990011_6399_Temozolomide_Day14.txt",
  "sheet_name": "None",
  "dataset_type": "All genes/guides",
  "metrics": ["count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Temozolomide_Day14"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA sequences used in the CRISPR screen to target specific genes."
    },
    {
      "dataset_filename_table_name_column_name": "Count",
      "interpretation": "The number of times each sgRNA was observed in the screen, indicating the abundance of the corresponding gene."
    }
  ]
}
{
  "article_title": "Genome Scale CRISPR Cas9a Knockout Screen Reveals Genes That Control Glioblastoma Susceptibility to the Alkylating Agent Temozolomide",
  "dataset_filename": "downloads/awahGenomeScaleCRISPR2022_35990011_6377_Library.txt",
  "sheet_name": "None",
  "dataset_type": "All genes/guides",
  "metrics": ["count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Glioblastoma CRISPR Screen"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA sequences used in the CRISPR screen to target specific genes."
    },
    {
      "dataset_filename_table_name_column_name": "Count",
      "interpretation": "The number of times each sgRNA was observed in the screen, indicating the abundance of the corresponding gene."
    }
  ]
}
{
  "article_title": "Genome Scale CRISPR Cas9a Knockout Screen Reveals Genes That Control Glioblastoma Susceptibility to the Alkylating Agent Temozolomide",
  "dataset_filename": "downloads/awahGenomeScaleCRISPR2022_35990011_6397_Puromycin_Day14.txt",
  "sheet_name": "None",
  "dataset_type": "All genes/guides",
  "metrics": ["count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Glioblastoma CRISPR Screen"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA sequences used in the CRISPR screen to target specific genes."
    },
    {
      "dataset_filename_table_name_column_name": "Count",
      "interpretation": "The number of times each sgRNA was observed in the screen, indicating its abundance or depletion."
    }
  ]
}
{
  "article_title": "Genome Scale CRISPR Cas9a Knockout Screen Reveals Genes That Control Glioblastoma Susceptibility to the Alkylating Agent Temozolomide",
  "dataset_filename": "downloads/awahGenomeScaleCRISPR2022_35990011_6398_DMSO_Day14.txt",
  "sheet_name": "None",
  "dataset_type": "All genes/guides",
  "metrics": ["count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Glioblastoma CRISPR Screen"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA sequences used in the CRISPR screen to target specific genes."
    },
    {
      "dataset_filename_table_name_column_name": "Count",
      "interpretation": "The number of times each sgRNA was observed in the screen, indicating its abundance or representation in the population of cells."
    }
  ]
}
{
  "article_title": "Ribosomal Protein S11 Influences Glioma Response to TOP2 Poisons",
  "dataset_filename": "downloads/awahRibosomalProteinS112020_32528131_NIHMS1599130-supplement-1599130_SuppList_Data_6.xlsx",
  "sheet_name": "CRISPR Read count Awah CU et.al",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR Read count Awah CU et.al"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "genes",
      "interpretation": "The gene symbol or identifier."
    },
    {
      "dataset_filename_table_name_column_name": "Eto R1",
      "interpretation": "The read count of gene knockout in the first replicate of etoposide treatment."
    },
    {
      "dataset_filename_table_name_column_name": "Eto R2",
      "interpretation": "The read count of gene knockout in the second replicate of etoposide treatment."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO",
      "interpretation": "The read count of gene knockout in the control (DMSO) condition."
    },
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA sequence used for gene knockout."
    },
    {
      "dataset_filename_table_name_column_name": "Puromycin R1",
      "interpretation": "The read count of gene knockout in the first replicate of puromycin selection."
    },
    {
      "dataset_filename_table_name_column_name": "Puromycin R2",
      "interpretation": "The read count of gene knockout in the second replicate of puromycin selection."
    },
    {
      "dataset_filename_table_name_column_name": "Library R1",
      "interpretation": "The read count of gene knockout in the first replicate of the library."
    },
    {
      "dataset_filename_table_name_column_name": "Library R2",
      "interpretation": "The read count of gene knockout in the second replicate of the library."
    }
  ]
}
{
  "article_title": "Ribosomal Protein S11 Influences Glioma Response to TOP2 Poisons",
  "dataset_filename": "downloads/awahRibosomalProteinS112020_32528131_NIHMS1599130-supplement-1599130_SuppList_Data_6.xlsx",
  "sheet_name": "Sheet2",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Sheet2"],
  "col_names_interpretations": []
}
{
  "article_title": "Ribosomal Protein S11 Influences Glioma Response to TOP2 Poisons",
  "dataset_filename": "downloads/awahRibosomalProteinS112020_32528131_NIHMS1599130-supplement-1599130_SuppList_Data_1B.xlsx",
  "sheet_name": "Sheet1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR knockout screen with etoposide"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Et > DMSO sgRSEA p < 0.01",
      "interpretation": "Enrichment score of sgRNAs targeting genes that are significantly differentially expressed between etoposide-treated and DMSO-treated cells, with a p-value less than 0.01."
    },
    {
      "dataset_filename_table_name_column_name": "Et > puro sgRSEA p < 0.01",
      "interpretation": "Enrichment score of sgRNAs targeting genes that are significantly differentially expressed between etoposide-treated and puromycin-treated cells, with a p-value less than 0.01."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO > Day 0 sgRSEA p<0.01",
      "interpretation": "Enrichment score of sgRNAs targeting genes that are significantly differentially expressed between DMSO-treated cells and cells at day 0, with a p-value less than 0.01."
    },
    {
      "dataset_filename_table_name_column_name": "Et > DMSO sgRSEA  OR Et > puro sgRSEA p < 0.01",
      "interpretation": "Overlap between the sets of genes identified as differentially expressed between etoposide-treated and DMSO-treated cells (p < 0.01) and between etoposide-treated and puromycin-treated cells (p < 0.01)."
    }
  ]
}
{
  "article_title": "ATM Orchestrates the DNA-damage Response to Counter Toxic Non-Homologous End-Joining at Broken Replication Forks",
  "dataset_filename": "downloads/balmusATMOrchestratesDNAdamage2019_30622252_41467_2018_7729_MOESM4_ESM.xlsx",
  "sheet_name": "test_BA6_yellow_50nm.pos.gene_s",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier."
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates or samples for the gene or sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score representing the abundance or activity of the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "(-)Log10 neg|p-value",
      "interpretation": "The negative logarithm (base 10) of the p-value for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the gene or sgRNA based on its score in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of 'good' sgRNAs for the gene in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score representing the abundance or activity of the gene or sgRNA in the positive condition (e.g., treated with topotecan)."
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the gene or sgRNA in the positive condition (e.g., treated with topotecan)."
    },
    {
      "dataset_filename_table_name_column_name": "(-)Log10 pos|p-value2",
      "interpretation": "The negative logarithm (base 10) of the adjusted p-value for the gene or sgRNA in the positive condition (e.g., treated with topotecan)."
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the gene or sgRNA in the positive condition (e.g., treated with topotecan)."
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene or sgRNA based on its score in the positive condition (e.g., treated with topotecan)."
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of 'good' sgRNAs for the gene in the positive condition (e.g., treated with topotecan)."
    }
  ]
}
{
  "article_title": "ATM Orchestrates the DNA-damage Response to Counter Toxic Non-Homologous End-Joining at Broken Replication Forks",
  "dataset_filename": "downloads/balmusATMOrchestratesDNAdamage2019_30622252_41467_2018_7729_MOESM3_ESM.xlsx",
  "sheet_name": "test_BA4_purple_400nM.pos.gene_",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier."
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates or samples for the gene or sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the gene or sgRNA in the negative condition."
    },
    {
      "dataset_filename_table_name_column_name": "(-)Log10 neg|p-value",
      "interpretation": "The negative log base 10 of the p-value for the gene or sgRNA in the negative condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the gene or sgRNA in the negative condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the gene or sgRNA in the negative condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the gene or sgRNA in the negative condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of good sgRNAs for the gene in the negative condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the gene or sgRNA in the positive condition."
    },
    {
      "dataset_filename_table_name_column_name": "(-)Log10 pos|p-value",
      "interpretation": "The negative log base 10 of the p-value for the gene or sgRNA in the positive condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the gene or sgRNA in the positive condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the gene or sgRNA in the positive condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene or sgRNA in the positive condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs for the gene in the positive condition."
    }
  ]
}
{
  "article_title": "Loss of the Abasic Site Sensor HMCES Is Synthetic Lethal with the Activity of the APOBEC3A Cytosine Deaminase in Cancer Cells",
  "dataset_filename": "downloads/biaynaLossAbasicSite2021_33788831_pbio.3001176.s014.xlsx",
  "sheet_name": "lfc_all_time_points",
  "dataset_type": "All genes/guides",
  "metrics": ["fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR Screen Data"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Gene symbol"
    },
    {
      "dataset_filename_table_name_column_name": "A549 TP53-/- time 9",
      "interpretation": "Log fold change of gene expression in A549 TP53-/- cells at time 9"
    },
    {
      "dataset_filename_table_name_column_name": "A549 TP53-/- time 12",
      "interpretation": "Log fold change of gene expression in A549 TP53-/- cells at time 12"
    },
    {
      "dataset_filename_table_name_column_name": "A549 TP53-/- time 15",
      "interpretation": "Log fold change of gene expression in A549 TP53-/- cells at time 15"
    },
    {
      "dataset_filename_table_name_column_name": "A549 TP53 WT time 9",
      "interpretation": "Log fold change of gene expression in A549 TP53 WT cells at time 9"
    },
    {
      "dataset_filename_table_name_column_name": "A549 TP53 WT time 12",
      "interpretation": "Log fold change of gene expression in A549 TP53 WT cells at time 12"
    },
    {
      "dataset_filename_table_name_column_name": "A549 TP53 WT time 15",
      "interpretation": "Log fold change of gene expression in A549 TP53 WT cells at time 15"
    },
    {
      "dataset_filename_table_name_column_name": "LXF289 DOX-IC25 time 5",
      "interpretation": "Log fold change of gene expression in LXF289 DOX-IC25 cells at time 5"
    },
    {
      "dataset_filename_table_name_column_name": "LXF289 DOX-IC25 time 10",
      "interpretation": "Log fold change of gene expression in LXF289 DOX-IC25 cells at time 10"
    },
    {
      "dataset_filename_table_name_column_name": "LXF289 DOX-IC25 time 15",
      "interpretation": "Log fold change of gene expression in LXF289 DOX-IC25 cells at time 15"
    },
    {
      "dataset_filename_table_name_column_name": "LXF289 DOX-IC50 time 5",
      "interpretation": "Log fold change of gene expression in LXF289 DOX-IC50 cells at time 5"
    },
    {
      "dataset_filename_table_name_column_name": "LXF289 DOX-IC50 time 10",
      "interpretation": "Log fold change of gene expression in LXF289 DOX-IC50 cells at time 10"
    },
    {
      "dataset_filename_table_name_column_name": "LXF289 DOX-IC50 time 15",
      "interpretation": "Log fold change of gene expression in LXF289 DOX-IC50 cells at time 15"
    }
  ]
}
{
  "article_title": "Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection",
  "dataset_filename": "downloads/caiCooperationATMFanconi2020_32075772_NIHMS1563617-supplement-3.xlsx",
  "sheet_name": "A549 STARS Negative",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["A549 STARS Negative"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene Symbol",
      "interpretation": "The symbol representing a specific gene targeted in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Number of perturbations",
      "interpretation": "The number of perturbations (gene knockouts) performed for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Ranks of perturbations",
      "interpretation": "The ranks of the perturbations for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Perturbations",
      "interpretation": "The sequences of the perturbations (sgRNAs) used for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Most enriched perturbation",
      "interpretation": "The perturbation (sgRNA) that resulted in the highest enrichment for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "STARS Score",
      "interpretation": "The STARS (Simplified T-statistic for Analysis of Ranked Screens) score for each gene, which represents the strength of the gene's effect."
    },
    {
      "dataset_filename_table_name_column_name": "Average Score",
      "interpretation": "The average score for each gene, calculated based on the individual scores of the perturbations targeting the gene."
    },
    {
      "dataset_filename_table_name_column_name": "p-value",
      "interpretation": "The p-value associated with the enrichment of each gene."
    },
    {
      "dataset_filename_table_name_column_name": "FDR",
      "interpretation": "The false discovery rate (FDR) associated with the enrichment of each gene."
    },
    {
      "dataset_filename_table_name_column_name": "q-value",
      "interpretation": "The q-value associated with the enrichment of each gene."
    }
  ]
}
{
  "article_title": "Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection",
  "dataset_filename": "downloads/caiCooperationATMFanconi2020_32075772_NIHMS1563617-supplement-3.xlsx",
  "sheet_name": "A549 STARS Positive",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["A549 STARS Positive"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene Symbol",
      "interpretation": "The symbol representing a specific gene."
    },
    {
      "dataset_filename_table_name_column_name": "Number of perturbations",
      "interpretation": "The number of perturbations performed for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Ranks of perturbations",
      "interpretation": "The ranks of the perturbations for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Perturbations",
      "interpretation": "The sequences of the perturbations for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Most enriched perturbation",
      "interpretation": "The most enriched perturbation for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "STARS Score",
      "interpretation": "The STARS score for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Average Score",
      "interpretation": "The average score for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "p-value",
      "interpretation": "The p-value for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "FDR",
      "interpretation": "The false discovery rate (FDR) for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "q-value",
      "interpretation": "The q-value for each gene."
    }
  ]
}
{
  "article_title": "Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection",
  "dataset_filename": "downloads/caiCooperationATMFanconi2020_32075772_NIHMS1563617-supplement-3.xlsx",
  "sheet_name": "H460 STARS Negative",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["H460 STARS Negative"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene Symbol",
      "interpretation": "The symbol representing a specific gene targeted in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Number of perturbations",
      "interpretation": "The number of perturbations (gene knockouts) performed for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Ranks of perturbations",
      "interpretation": "The ranks of the perturbations (gene knockouts) performed for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Perturbations",
      "interpretation": "The sequences of the perturbations (gene knockouts) performed for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Most enriched perturbation",
      "interpretation": "The most enriched perturbation sequence for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "STARS Score",
      "interpretation": "The STARS (Simplified T-statistic for Analysis of Ranked Screens) score for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Average Score",
      "interpretation": "The average score for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "p-value",
      "interpretation": "The p-value for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "FDR",
      "interpretation": "The false discovery rate (FDR) for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "q-value",
      "interpretation": "The q-value for each gene."
    }
  ]
}
{
  "article_title": "Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection",
  "dataset_filename": "downloads/caiCooperationATMFanconi2020_32075772_NIHMS1563617-supplement-3.xlsx",
  "sheet_name": "H460 STARS Positive",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["H460 STARS Positive"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene Symbol",
      "interpretation": "The symbol representing a specific gene."
    },
    {
      "dataset_filename_table_name_column_name": "Number of perturbations",
      "interpretation": "The number of perturbations performed for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Ranks of perturbations",
      "interpretation": "The ranks of the perturbations for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Perturbations",
      "interpretation": "The sequences of the perturbations for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Most enriched perturbation",
      "interpretation": "The most enriched perturbation for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "STARS Score",
      "interpretation": "The STARS score for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "Average Score",
      "interpretation": "The average score for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "p-value",
      "interpretation": "The p-value for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "FDR",
      "interpretation": "The false discovery rate (FDR) for each gene."
    },
    {
      "dataset_filename_table_name_column_name": "q-value",
      "interpretation": "The q-value for each gene."
    }
  ]
}
{
  "article_title": "Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection",
  "dataset_filename": "downloads/caiCooperationATMFanconi2020_32075772_NIHMS1563617-supplement-2.xlsx",
  "sheet_name": "A549",
  "dataset_type": "All genes/guides",
  "metrics": ["fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Barcode Sequence",
      "interpretation": "The barcode sequence of the gene or sgRNA targeted in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Log 2 fold change (A549: ATMi vs DMSO)",
      "interpretation": "The log2 fold change in gene or sgRNA abundance in A549 cells treated with an ATM inhibitor (ATMi) compared to cells treated with DMSO (control)."
    }
  ]
}
{
  "article_title": "Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection",
  "dataset_filename": "downloads/caiCooperationATMFanconi2020_32075772_NIHMS1563617-supplement-2.xlsx",
  "sheet_name": "H460",
  "dataset_type": "All genes/guides",
  "metrics": ["fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Barcode Sequence",
      "interpretation": "The barcode sequence of the sgRNA used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Log 2 fold change (H460: ATMi vs DMSO)",
      "interpretation": "The log2 fold change in abundance of the sgRNA in H460 cells treated with an ATM inhibitor (ATMi) compared to cells treated with DMSO (control)."
    }
  ]
}
{
  "article_title": "Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection",
  "dataset_filename": "downloads/caiCooperationATMFanconi2020_32075772_NIHMS1563617-supplement-2.xlsx",
  "sheet_name": "CP0041_20170705_compat_chip",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Barcode Sequence",
      "interpretation": "The unique sequence identifier for each guide RNA used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Annotated Gene Symbol",
      "interpretation": "The symbol representing the gene targeted by the guide RNA."
    },
    {
      "dataset_filename_table_name_column_name": "Annotated Gene ID",
      "interpretation": "The unique identifier for the gene targeted by the guide RNA."
    }
  ]
}
{
  "article_title": "The Genomic Landscape of Sensitivity to Arsenic Trioxide Uncovered by Genome-Wide CRISPR-Cas9 Screening",
  "dataset_filename": "downloads/chenGenomicLandscapeSensitivity2023_37251921_Table_1.xlsx",
  "sheet_name": "ATO_normalized-total.gene_summa",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["ATO_normalized-total.gene_summa"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene symbol or identifier"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score representing the significance of the gene's association with ATO sensitivity. Lower scores indicate higher significance."
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value representing the significance of the gene's association with ATO sensitivity. Lower p-values indicate higher significance."
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) representing the adjusted p-value for multiple testing. Lower FDR values indicate higher significance."
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene based on its association with ATO sensitivity. Lower ranks indicate higher significance."
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs (single-guide RNAs) targeting the gene."
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change (LFC) representing the change in gene expression upon ATO treatment. Positive values indicate upregulation, while negative values indicate downregulation."
    }
  ]
}
{
  "article_title": "Identifying CDC7 as a Synergistic Target of Chemotherapy in Resistant Small-Cell Lung Cancer via CRISPR/Cas9 Screening",
  "dataset_filename": "downloads/dengIdentifyingCDC7Synergistic2023_36725843_41420_2023_1315_MOESM8_ESM.xlsx",
  "sheet_name": "Sheet1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||num",
      "interpretation": "The number of times the gene or sgRNA was found in the screen."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||neg|p-value",
      "interpretation": "The p-value for the negative selection of the gene or sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the negative selection of the gene or sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||neg|rank",
      "interpretation": "The rank of the gene or sgRNA in the negative selection."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||neg|goodsgrna",
      "interpretation": "The number of good sgRNAs targeting the gene in the negative selection."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||pos|p-value",
      "interpretation": "The p-value for the positive selection of the gene or sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the positive selection of the gene or sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||pos|rank",
      "interpretation": "The rank of the gene or sgRNA in the positive selection."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||pos|goodsgrna",
      "interpretation": "The number of good sgRNAs targeting the gene in the positive selection."
    },
    {
      "dataset_filename_table_name_column_name": "d7_chemo__d7_control||log2FoldChange",
      "interpretation": "The log2 fold change of the gene or sgRNA in the screen."
    }
  ]
}
{
  "article_title": "Genome-Scale CRISPR Screen Reveals Neddylation to Contribute to Cisplatin Resistance of Testicular Germ Cell Tumours",
  "dataset_filename": "downloads/funkeGenomescaleCRISPRScreen2023_37024667_41416_2023_2247_MOESM3_ESM.xlsx",
  "sheet_name": "info",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["info"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Column containing information about the dataset"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Additional information about the dataset"
    }
  ]
}
{
  "article_title": "Genome-Scale CRISPR Screen Reveals Neddylation to Contribute to Cisplatin Resistance of Testicular Germ Cell Tumours",
  "dataset_filename": "downloads/funkeGenomescaleCRISPRScreen2023_37024667_41416_2023_2247_MOESM3_ESM.xlsx",
  "sheet_name": "1_2102EP_CP",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "Average gene or sgRNA abundance across samples"
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "Log2 fold change in gene or sgRNA abundance between conditions"
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "Standard error of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "P-value for the statistical significance of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "Adjusted p-value for multiple testing correction"
    },
    {
      "dataset_filename_table_name_column_name": "chromosome",
      "interpretation": "Chromosome location of the gene or sgRNA"
    },
    {
      "dataset_filename_table_name_column_name": "ens_gene",
      "interpretation": "Ensembl gene ID"
    },
    {
      "dataset_filename_table_name_column_name": "ext_gene",
      "interpretation": "External gene symbol"
    }
  ]
}
{
  "article_title": "Genome-Scale CRISPR Screen Reveals Neddylation to Contribute to Cisplatin Resistance of Testicular Germ Cell Tumours",
  "dataset_filename": "downloads/funkeGenomescaleCRISPRScreen2023_37024667_41416_2023_2247_MOESM3_ESM.xlsx",
  "sheet_name": "2_2102EP_MLN",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR Screen Data"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "Average gene or sgRNA expression level"
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "Log2 fold change in gene or sgRNA expression between conditions"
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "Standard error of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "P-value for the significance of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "Adjusted p-value for multiple testing correction"
    },
    {
      "dataset_filename_table_name_column_name": "chromosome",
      "interpretation": "Chromosome location of the gene or sgRNA"
    },
    {
      "dataset_filename_table_name_column_name": "ens_gene",
      "interpretation": "Ensembl gene ID"
    },
    {
      "dataset_filename_table_name_column_name": "ext_gene",
      "interpretation": "External gene symbol"
    }
  ]
}
{
  "article_title": "Genome-Scale CRISPR Screen Reveals Neddylation to Contribute to Cisplatin Resistance of Testicular Germ Cell Tumours",
  "dataset_filename": "downloads/funkeGenomescaleCRISPRScreen2023_37024667_41416_2023_2247_MOESM3_ESM.xlsx",
  "sheet_name": "3_2102EP_MLN_CP",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR Screen Data"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "Average gene or sgRNA abundance across samples"
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "Log2 fold change in gene or sgRNA abundance between conditions"
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "Standard error of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "P-value for the statistical significance of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "Adjusted p-value for multiple testing correction"
    },
    {
      "dataset_filename_table_name_column_name": "chromosome",
      "interpretation": "Chromosome location of the gene"
    },
    {
      "dataset_filename_table_name_column_name": "ens_gene",
      "interpretation": "Ensembl gene ID"
    },
    {
      "dataset_filename_table_name_column_name": "ext_gene",
      "interpretation": "External gene symbol"
    }
  ]
}
{
  "article_title": "Genome-Scale CRISPR Screen Reveals Neddylation to Contribute to Cisplatin Resistance of Testicular Germ Cell Tumours",
  "dataset_filename": "downloads/funkeGenomescaleCRISPRScreen2023_37024667_41416_2023_2247_MOESM3_ESM.xlsx",
  "sheet_name": "4_JAR_CP",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR Screen Data"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "Average gene or sgRNA abundance across samples"
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "Log2 fold change in gene or sgRNA abundance between conditions"
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "Standard error of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "P-value for the statistical significance of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "Adjusted p-value for multiple testing correction"
    },
    {
      "dataset_filename_table_name_column_name": "chromosome",
      "interpretation": "Chromosome location of the gene or sgRNA"
    },
    {
      "dataset_filename_table_name_column_name": "ens_gene",
      "interpretation": "Ensembl gene ID"
    },
    {
      "dataset_filename_table_name_column_name": "ext_gene",
      "interpretation": "External gene identifier"
    }
  ]
}
{
  "article_title": "Genome-Scale CRISPR Screen Reveals Neddylation to Contribute to Cisplatin Resistance of Testicular Germ Cell Tumours",
  "dataset_filename": "downloads/funkeGenomescaleCRISPRScreen2023_37024667_41416_2023_2247_MOESM3_ESM.xlsx",
  "sheet_name": "5_JAR_MLN",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR Screen Data"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "Average gene or sgRNA abundance across samples"
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "Log2 fold change in gene or sgRNA abundance between conditions"
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "Standard error of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "P-value for the statistical significance of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "Adjusted p-value for multiple testing correction"
    },
    {
      "dataset_filename_table_name_column_name": "chromosome",
      "interpretation": "Chromosome location of the gene"
    },
    {
      "dataset_filename_table_name_column_name": "ens_gene",
      "interpretation": "Ensembl gene ID"
    },
    {
      "dataset_filename_table_name_column_name": "ext_gene",
      "interpretation": "External gene name"
    }
  ]
}
{
  "article_title": "Genome-Scale CRISPR Screen Reveals Neddylation to Contribute to Cisplatin Resistance of Testicular Germ Cell Tumours",
  "dataset_filename": "downloads/funkeGenomescaleCRISPRScreen2023_37024667_41416_2023_2247_MOESM3_ESM.xlsx",
  "sheet_name": "6_JAR_MLN_CP",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["6_JAR_MLN_CP"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "Average gene or sgRNA abundance across samples"
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "Log2 fold change in gene or sgRNA abundance between conditions"
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "Standard error of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "P-value for the statistical significance of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "Adjusted p-value for multiple testing correction"
    },
    {
      "dataset_filename_table_name_column_name": "chromosome",
      "interpretation": "Chromosome location of the gene or sgRNA"
    },
    {
      "dataset_filename_table_name_column_name": "ens_gene",
      "interpretation": "Ensembl gene ID"
    },
    {
      "dataset_filename_table_name_column_name": "ext_gene",
      "interpretation": "External gene name"
    }
  ]
}
{
  "article_title": "Genome-Scale CRISPR Screen Reveals Neddylation to Contribute to Cisplatin Resistance of Testicular Germ Cell Tumours",
  "dataset_filename": "downloads/funkeGenomescaleCRISPRScreen2023_37024667_41416_2023_2247_MOESM3_ESM.xlsx",
  "sheet_name": "7_NGS_Cand_list",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR Screen Dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene Name",
      "interpretation": "The name of the gene targeted by the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "Refseq ID",
      "interpretation": "The reference sequence ID of the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Target sequence sgRNA",
      "interpretation": "The sequence of the sgRNA used to target the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Read counts",
      "interpretation": "The number of reads corresponding to the gene/sgRNA."
    }
  ]
}
{
  "article_title": "CCNE1 Amplification Is Synthetic Lethal with PKMYT1 Kinase Inhibition",
  "dataset_filename": "downloads/galloCCNE1AmplificationSynthetic2022_35444283_41586_2022_4638_MOESM3_ESM.xlsx",
  "sheet_name": "ReadCounts TKOv2 CCNE1 SL",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["ReadCounts TKOv2 CCNE1 SL"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA sequence used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene targeted by the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T0",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#2 at time point T0."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T15_repA",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#2 at time point T15, replicate A."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T15_repB",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#2 at time point T15, replicate B."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T18_repA",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#2 at time point T18, replicate A."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T18_repB",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#2 at time point T18, replicate B."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#21_T0",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#21 at time point T0."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#21_T15_repA",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#21 at time point T15, replicate A."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#21_T15_repB",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#21 at time point T15, replicate B."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#21_T18_repA",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#21 at time point T18, replicate A."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#21_T18_repB",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53_CCNE1oe Clone#21 at time point T18, replicate B."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_T0",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53 at time point T0."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_WT_T18_repA",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53 wild type at time point T18, replicate A."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv2_RPE1.hTERT.Cas9.dTP53_T18_repB",
      "interpretation": "The read count for the TKOv2 screen using RPE1.hTERT.Cas9.dTP53 at time point T18, replicate B."
    }
  ]
}
{
  "article_title": "CCNE1 Amplification Is Synthetic Lethal with PKMYT1 Kinase Inhibition",
  "dataset_filename": "downloads/galloCCNE1AmplificationSynthetic2022_35444283_41586_2022_4638_MOESM3_ESM.xlsx",
  "sheet_name": "ReadCounts_TKOv3 CCNE1 SL",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["ReadCounts_TKOv3 CCNE1 SL"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene targeted by the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T0",
      "interpretation": "The read count for the TKOv3_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T0 condition."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T18A",
      "interpretation": "The read count for the TKOv3_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T18A condition."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T18B",
      "interpretation": "The read count for the TKOv3_RPE1.hTERT.Cas9.dTP53_CCNE1oe_Clone#2_T18B condition."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_RPE1.hTERT.Cas9.dTP53_WT_T0",
      "interpretation": "The read count for the TKOv3_RPE1.hTERT.Cas9.dTP53_WT_T0 condition."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_RPE1.hTERT.Cas9.dTP53_WT_T18A",
      "interpretation": "The read count for the TKOv3_RPE1.hTERT.Cas9.dTP53_WT_T18A condition."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_RPE1.hTERT.Cas9.dTP53_WT_T18B",
      "interpretation": "The read count for the TKOv3_RPE1.hTERT.Cas9.dTP53_WT_T18B condition."
    }
  ]
}
{
  "article_title": "CCNE1 Amplification Is Synthetic Lethal with PKMYT1 Kinase Inhibition",
  "dataset_filename": "downloads/galloCCNE1AmplificationSynthetic2022_35444283_41586_2022_4638_MOESM3_ESM.xlsx",
  "sheet_name": "ReadCounts RP-6306 resistance",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["ReadCounts RP-6306 resistance"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA sequence used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene targeted by the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_FT282.CCNE1oe_C3_NT_T6A",
      "interpretation": "Read counts for TKOv3_FT282.CCNE1oe_C3_NT_T6A."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_FT282.CCNE1oe_C3_NT_T6B",
      "interpretation": "Read counts for TKOv3_FT282.CCNE1oe_C3_NT_T6B."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_FT282.CCNE1oe_C4_NT_T6A",
      "interpretation": "Read counts for TKOv3_FT282.CCNE1oe_C4_NT_T6A."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_FT282.CCNE1oe_C4_NT_T6B",
      "interpretation": "Read counts for TKOv3_FT282.CCNE1oe_C4_NT_T6B."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_FT282.CCNE1oe_C3_RP6306_T21A",
      "interpretation": "Read counts for TKOv3_FT282.CCNE1oe_C3_RP6306_T21A."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_FT282.CCNE1oe_C3_RP6306_T21B",
      "interpretation": "Read counts for TKOv3_FT282.CCNE1oe_C3_RP6306_T21B."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_FT282.CCNE1oe_C4_RP6306_T21A",
      "interpretation": "Read counts for TKOv3_FT282.CCNE1oe_C4_RP6306_T21A."
    },
    {
      "dataset_filename_table_name_column_name": "TKOv3_FT282.CCNE1oe_C4_RP6306_T21B",
      "interpretation": "Read counts for TKOv3_FT282.CCNE1oe_C4_RP6306_T21B."
    }
  ]
}
{
  "article_title": "A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer",
  "dataset_filename": "downloads/goodspeedWholegenomeCRISPRScreen2019_30414698_NIHMS1510205-supplement-1.xlsx",
  "sheet_name": "Supplementary Table 1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Table 1"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene targeted by the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "TRC#",
      "interpretation": "The TRC number associated with the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Study Abreviation",
      "interpretation": "The abbreviation of the study in which the gene was knocked down."
    },
    {
      "dataset_filename_table_name_column_name": "Clone ID",
      "interpretation": "The ID of the clone used for knocking down the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Sequence",
      "interpretation": "The sequence of the shRNA used for knocking down the gene."
    }
  ]
}
{
  "article_title": "A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer",
  "dataset_filename": "downloads/goodspeedWholegenomeCRISPRScreen2019_30414698_NIHMS1510205-supplement-1.xlsx",
  "sheet_name": "Supplementary Table 2",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Table 2"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Antibody"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "Vendor Cat. Number"
    }
  ]
}
{
  "article_title": "A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer",
  "dataset_filename": "downloads/goodspeedWholegenomeCRISPRScreen2019_30414698_NIHMS1510205-supplement-1.xlsx",
  "sheet_name": "Supplementary Table 3",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Table 3"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Primer set",
      "interpretation": "The name of the primer set used in the study."
    },
    {
      "dataset_filename_table_name_column_name": "Forward sequence",
      "interpretation": "The forward sequence of the qRTPCR primer."
    },
    {
      "dataset_filename_table_name_column_name": "Reverse sequence",
      "interpretation": "The reverse sequence of the qRTPCR primer."
    }
  ]
}
{
  "article_title": "A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer",
  "dataset_filename": "downloads/goodspeedWholegenomeCRISPRScreen2019_30414698_NIHMS1510205-supplement-1.xlsx",
  "sheet_name": "Supplementary Table 4",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Bladder Cancer Data from TCGA"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "ID",
      "interpretation": "The ID of the bladder cancer sample."
    },
    {
      "dataset_filename_table_name_column_name": "Survival_status",
      "interpretation": "The survival status of the patient (Dead or Alive)."
    },
    {
      "dataset_filename_table_name_column_name": "Survival_days",
      "interpretation": "The number of days the patient survived."
    },
    {
      "dataset_filename_table_name_column_name": "Stage",
      "interpretation": "The stage of the bladder cancer."
    },
    {
      "dataset_filename_table_name_column_name": "Lymph_status",
      "interpretation": "The lymph node status of the bladder cancer."
    },
    {
      "dataset_filename_table_name_column_name": "Metastasis_status",
      "interpretation": "The metastasis status of the bladder cancer."
    },
    {
      "dataset_filename_table_name_column_name": "Grade",
      "interpretation": "The grade of the bladder cancer."
    },
    {
      "dataset_filename_table_name_column_name": "Age",
      "interpretation": "The age of the patient."
    },
    {
      "dataset_filename_table_name_column_name": "Platinum_treated",
      "interpretation": "Whether the patient was treated with platinum-based therapy (0 or 1)."
    },
    {
      "dataset_filename_table_name_column_name": "Pharm_no_plat",
      "interpretation": "The number of patients not treated with platinum-based therapy."
    },
    {
      "dataset_filename_table_name_column_name": "Radiation",
      "interpretation": "Whether the patient received radiation therapy (0 or 1)."
    },
    {
      "dataset_filename_table_name_column_name": "No_pharm_or_radiation",
      "interpretation": "Whether the patient received neither pharmaceutical nor radiation therapy (0 or 1)."
    },
    {
      "dataset_filename_table_name_column_name": "Best.platinum.response",
      "interpretation": "The best response to platinum-based therapy."
    },
    {
      "dataset_filename_table_name_column_name": "Best.non.platinum.response",
      "interpretation": "The best response to non-platinum-based therapy."
    },
    {
      "dataset_filename_table_name_column_name": "Cystectomy",
      "interpretation": "Whether the patient underwent cystectomy (0 or 1)."
    },
    {
      "dataset_filename_table_name_column_name": "MSH2_RPPA",
      "interpretation": "The MSH2 protein level measured using reverse-phase protein array."
    },
    {
      "dataset_filename_table_name_column_name": "MSH6_RPPA",
      "interpretation": "The MSH6 protein level measured using reverse-phase protein array."
    },
    {
      "dataset_filename_table_name_column_name": "Neoantigens",
      "interpretation": "The number of neoantigens."
    },
    {
      "dataset_filename_table_name_column_name": "SNV",
      "interpretation": "The number of single nucleotide variants."
    },
    {
      "dataset_filename_table_name_column_name": "Indels",
      "interpretation": "The number of insertions and deletions."
    },
    {
      "dataset_filename_table_name_column_name": "MSH2_RSEM",
      "interpretation": "The MSH2 gene expression level measured using RNA-Seq by Expectation Maximization."
    },
    {
      "dataset_filename_table_name_column_name": "MSH2_RPPA_tertile",
      "interpretation": "The tertile classification of MSH2 protein level based on reverse-phase protein array."
    }
  ]
}
{
  "article_title": "A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer",
  "dataset_filename": "downloads/goodspeedWholegenomeCRISPRScreen2019_30414698_NIHMS1510205-supplement-1.xlsx",
  "sheet_name": "Supplementary Table 5",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Table 5"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA used in the CRISPR screen to target specific genes."
    },
    {
      "dataset_filename_table_name_column_name": "Cisplatin1",
      "interpretation": "The raw count of cells with sgRNA treatment and cisplatin exposure in replicate 1."
    },
    {
      "dataset_filename_table_name_column_name": "Cisplatin2",
      "interpretation": "The raw count of cells with sgRNA treatment and cisplatin exposure in replicate 2."
    },
    {
      "dataset_filename_table_name_column_name": "Cisplatin3",
      "interpretation": "The raw count of cells with sgRNA treatment and cisplatin exposure in replicate 3."
    },
    {
      "dataset_filename_table_name_column_name": "Cisplatin4",
      "interpretation": "The raw count of cells with sgRNA treatment and cisplatin exposure in replicate 4."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO1",
      "interpretation": "The raw count of cells with sgRNA treatment and DMSO control in replicate 1."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO2",
      "interpretation": "The raw count of cells with sgRNA treatment and DMSO control in replicate 2."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO3",
      "interpretation": "The raw count of cells with sgRNA treatment and DMSO control in replicate 3."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO4",
      "interpretation": "The raw count of cells with sgRNA treatment and DMSO control in replicate 4."
    }
  ]
}
{
  "article_title": "A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer",
  "dataset_filename": "downloads/goodspeedWholegenomeCRISPRScreen2019_30414698_NIHMS1510205-supplement-1.xlsx",
  "sheet_name": "Supplementary Table 6",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Table 6"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol of the target gene"
    },
    {
      "dataset_filename_table_name_column_name": "Log2_FC1",
      "interpretation": "The log2 fold change of gene expression in condition 1 compared to the control"
    },
    {
      "dataset_filename_table_name_column_name": "pval1",
      "interpretation": "The p-value associated with the fold change in condition 1 compared to the control"
    }
  ]
}
{
  "article_title": "A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer",
  "dataset_filename": "downloads/goodspeedWholegenomeCRISPRScreen2019_30414698_NIHMS1510205-supplement-1.xlsx",
  "sheet_name": "Supplementary Table 7",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Table 7"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Patient characteristic"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "MSH2 level"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "Medium/high level"
    }
  ]
}
{
  "article_title": "A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer",
  "dataset_filename": "downloads/goodspeedWholegenomeCRISPRScreen2019_30414698_NIHMS1510205-supplement-1.xlsx",
  "sheet_name": "Supplementary Table 8",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Table 8"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "MSH2 level"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "Medium/high MSH2 level"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "P-value"
    }
  ]
}
{
  "article_title": "{{DYNLL1}} Binds {{MRE11}} to Limit {{DNA}} End Resection in {{BRCA1-deficient}} Cells",
  "dataset_filename": "downloads/heDYNLL1BindsMRE112018_30464262_NIHMS1567675-supplement-Table_1.xlsx",
  "sheet_name": "Cov362 Olaparib",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Cov362 Olaparib"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene Symbol",
      "interpretation": "The symbol representing a gene that was perturbed in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Number of perturbations",
      "interpretation": "The number of times the gene was perturbed in the screen."
    },
    {
      "dataset_filename_table_name_column_name": "Ranks of perturbations",
      "interpretation": "The ranks of the perturbations for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Perturbations",
      "interpretation": "The sequences of the perturbations for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Most enriched perturbation",
      "interpretation": "The most enriched perturbation for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "STARS Score",
      "interpretation": "The STARS score for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Average Score",
      "interpretation": "The average score for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "p-value",
      "interpretation": "The p-value for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "FDR",
      "interpretation": "The false discovery rate (FDR) for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "q-value",
      "interpretation": "The q-value for the gene."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR-Cas9 Screening Identifies NF-B/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma",
  "dataset_filename": "downloads/huangGenomeWideCRISPR2019_31508283_ADVS-6-1900782-s006.xlsx",
  "sheet_name": "B-1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Differential sgRNAs between U87 EGFRvIII cells treated with DMSO or temozolomide in day 7"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "ID",
      "interpretation": "The identifier of the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "Entry",
      "interpretation": "The gene targeted by the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO Log FC",
      "interpretation": "The log fold change in sgRNA abundance between U87 EGFRvIII cells treated with DMSO and temozolomide."
    },
    {
      "dataset_filename_table_name_column_name": "TMZ Log FC",
      "interpretation": "The log fold change in sgRNA abundance between U87 EGFRvIII cells treated with temozolomide and DMSO."
    },
    {
      "dataset_filename_table_name_column_name": "Up/Down",
      "interpretation": "Indicates whether the sgRNA is upregulated or downregulated in response to temozolomide treatment."
    },
    {
      "dataset_filename_table_name_column_name": "Druggable like",
      "interpretation": "Indicates whether the targeted gene is druggable or has druggable-like properties. [unclear]"
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR-Cas9 Screening Identifies NF-B/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma",
  "dataset_filename": "downloads/huangGenomeWideCRISPR2019_31508283_ADVS-6-1900782-s006.xlsx",
  "sheet_name": "B-2",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "ID",
      "interpretation": "The identifier of the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "Entry",
      "interpretation": "The gene targeted by the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO Log FC",
      "interpretation": "The log fold change in gene expression in cells treated with DMSO compared to untreated cells."
    },
    {
      "dataset_filename_table_name_column_name": "TMZ Log FC",
      "interpretation": "The log fold change in gene expression in cells treated with temozolomide (TMZ) compared to untreated cells."
    },
    {
      "dataset_filename_table_name_column_name": "Up/Down",
      "interpretation": "Indicates whether the gene is upregulated or downregulated in response to treatment."
    },
    {
      "dataset_filename_table_name_column_name": "Druggable like",
      "interpretation": "Indicates whether the gene is potentially druggable for targeted therapy."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR-Cas9 Screening Identifies NF-B/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma",
  "dataset_filename": "downloads/huangGenomeWideCRISPR2019_31508283_ADVS-6-1900782-s005.xlsx",
  "sheet_name": "A-1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Table 1"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "ID",
      "interpretation": "The identifier of the sgRNA"
    },
    {
      "dataset_filename_table_name_column_name": "Entry",
      "interpretation": "The gene symbol"
    },
    {
      "dataset_filename_table_name_column_name": "DMSO Log FC",
      "interpretation": "The log fold change of sgRNA abundance in DMSO-treated cells compared to day 0"
    },
    {
      "dataset_filename_table_name_column_name": "DMSO significance",
      "interpretation": "The significance of the DMSO Log FC"
    },
    {
      "dataset_filename_table_name_column_name": "TMZ Log FC",
      "interpretation": "The log fold change of sgRNA abundance in TMZ-treated cells compared to day 0"
    },
    {
      "dataset_filename_table_name_column_name": "TMZ significance",
      "interpretation": "The significance of the TMZ Log FC"
    },
    {
      "dataset_filename_table_name_column_name": "Druggable like",
      "interpretation": "Indicates if the gene is druggable or not"
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR-Cas9 Screening Identifies NF-B/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma",
  "dataset_filename": "downloads/huangGenomeWideCRISPR2019_31508283_ADVS-6-1900782-s005.xlsx",
  "sheet_name": "A-2",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Table 1"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "ID",
      "interpretation": "The identifier of the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "Entry",
      "interpretation": "The gene targeted by the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO Log FC",
      "interpretation": "The log fold change in sgRNA abundance between day 7 and day 0 in DMSO-treated cells."
    },
    {
      "dataset_filename_table_name_column_name": "DMSO significance",
      "interpretation": "The significance of the log fold change in DMSO-treated cells."
    },
    {
      "dataset_filename_table_name_column_name": "TMZ Log FC",
      "interpretation": "The log fold change in sgRNA abundance between day 7 and day 0 in temozolomide-treated cells."
    },
    {
      "dataset_filename_table_name_column_name": "TMZ significance",
      "interpretation": "The significance of the log fold change in temozolomide-treated cells."
    },
    {
      "dataset_filename_table_name_column_name": "Druggable like",
      "interpretation": "Indicates whether the targeted gene is druggable or not."
    }
  ]
}
{
  "article_title": "CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer",
  "dataset_filename": "downloads/lanCRISPRCas9ScreenIdentifies2022_35053488_cancers-14-00326-s001.xlsx",
  "sheet_name": "RT-2D",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR-Cas9 Radiotherapy Screening Results-2D"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of good sgRNAs for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change for the positive control"
    }
  ]
}
{
  "article_title": "CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer",
  "dataset_filename": "downloads/lanCRISPRCas9ScreenIdentifies2022_35053488_cancers-14-00326-s001.xlsx",
  "sheet_name": "RT-3D",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR-Cas9 Radiotherapy Screening Results-3D"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the negative control group"
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the negative control group"
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the negative control group"
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the gene or sgRNA in the negative control group"
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of good sgRNAs in the negative control group"
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change for the negative control group"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the positive control group"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the positive control group"
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the positive control group"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene or sgRNA in the positive control group"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs in the positive control group"
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change for the positive control group"
    }
  ]
}
{
  "article_title": "mTOR Inhibition Attenuates Chemosensitivity through the Induction of Chemotherapy Resistant Persisters",
  "dataset_filename": "downloads/liuMTORInhibitionAttenuates2022_36396656_41467_2022_34890_MOESM5_ESM.xlsx",
  "sheet_name": "Supplementary Data 1a",
  "dataset_type": "All genes/guides",
  "metrics": ["score"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Data 1a"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol"
    },
    {
      "dataset_filename_table_name_column_name": "Gemcitabine_versus_control",
      "interpretation": "The  score of the gene in the gemcitabine versus control screen"
    },
    {
      "dataset_filename_table_name_column_name": "Selinexor_versus_control",
      "interpretation": "The  score of the gene in the selinexor versus control screen"
    }
  ]
}
{
  "article_title": "mTOR Inhibition Attenuates Chemosensitivity through the Induction of Chemotherapy Resistant Persisters",
  "dataset_filename": "downloads/liuMTORInhibitionAttenuates2022_36396656_41467_2022_34890_MOESM5_ESM.xlsx",
  "sheet_name": "Supplementary Data 1b",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Data 1b"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Supplementary Data 1b_gene",
      "interpretation": "The gene symbol or identifier."
    }
  ]
}
{
  "article_title": "mTOR Inhibition Attenuates Chemosensitivity through the Induction of Chemotherapy Resistant Persisters",
  "dataset_filename": "downloads/liuMTORInhibitionAttenuates2022_36396656_41467_2022_34890_MOESM5_ESM.xlsx",
  "sheet_name": "Supplementary Data 1c",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Data 1c"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Supplementary Data 1c_gene",
      "interpretation": "List of genes depleted in both gemcitabine and selinxor screens."
    }
  ]
}
{
  "article_title": "mTOR Inhibition Attenuates Chemosensitivity through the Induction of Chemotherapy Resistant Persisters",
  "dataset_filename": "downloads/liuMTORInhibitionAttenuates2022_36396656_41467_2022_34890_MOESM5_ESM.xlsx",
  "sheet_name": "Supplementary Data 1d",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["GO term enrichment analysis of enriched genes"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Term",
      "interpretation": "The Gene Ontology (GO) term associated with the biological process or molecular function."
    },
    {
      "dataset_filename_table_name_column_name": "Overlap",
      "interpretation": "The number of genes in the dataset that overlap with the GO term."
    },
    {
      "dataset_filename_table_name_column_name": "P-value",
      "interpretation": "The statistical significance of the enrichment of the GO term."
    },
    {
      "dataset_filename_table_name_column_name": "Adjusted P-value",
      "interpretation": "The adjusted p-value after multiple testing correction."
    },
    {
      "dataset_filename_table_name_column_name": "Odds Ratio",
      "interpretation": "The odds ratio of the enrichment of the GO term."
    },
    {
      "dataset_filename_table_name_column_name": "Combined Score",
      "interpretation": "The combined score of the enrichment of the GO term."
    },
    {
      "dataset_filename_table_name_column_name": "Genes",
      "interpretation": "The list of genes associated with the GO term."
    }
  ]
}
{
  "article_title": "mTOR Inhibition Attenuates Chemosensitivity through the Induction of Chemotherapy Resistant Persisters",
  "dataset_filename": "downloads/liuMTORInhibitionAttenuates2022_36396656_41467_2022_34890_MOESM5_ESM.xlsx",
  "sheet_name": "Supplementary Data 1e",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "Adjusted P-value", "Odds Ratio", "Combined Score"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Data 1e"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Term",
      "interpretation": "GO term describing a biological process or function that is enriched in the depleted genes"
    },
    {
      "dataset_filename_table_name_column_name": "Overlap",
      "interpretation": "Number of genes in the dataset that overlap with the GO term"
    },
    {
      "dataset_filename_table_name_column_name": "P-value",
      "interpretation": "P-value indicating the statistical significance of the enrichment of the GO term"
    },
    {
      "dataset_filename_table_name_column_name": "Adjusted P-value",
      "interpretation": "Adjusted P-value accounting for multiple testing"
    },
    {
      "dataset_filename_table_name_column_name": "Odds Ratio",
      "interpretation": "Ratio of the odds of observing the GO term in the dataset compared to the odds of observing it in the background"
    },
    {
      "dataset_filename_table_name_column_name": "Combined Score",
      "interpretation": "Score combining the statistical significance and the magnitude of enrichment of the GO term"
    },
    {
      "dataset_filename_table_name_column_name": "Genes",
      "interpretation": "List of genes in the dataset that are associated with the GO term"
    }
  ]
}
{
  "article_title": "Spindle Assembly Checkpoint Inhibition Can Resensitize P53-Null Stem Cells to Cancer Chemotherapy",
  "dataset_filename": "downloads/liuSpindleAssemblyCheckpoint2019_30862715_NIHMS1524158-supplement-5.xlsx",
  "sheet_name": "Cisplatin_DMF_gene_summary.txt",
  "dataset_type": "All genes/guides",
  "metrics": ["score", "p-value"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Cisplatin_DMF_gene_summary"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "negative selection score",
      "interpretation": "The score representing the negative selection of each gene. Lower scores indicate higher negative selection."
    },
    {
      "dataset_filename_table_name_column_name": "negative selection p-value",
      "interpretation": "The p-value representing the significance of the negative selection score for each gene. Lower p-values indicate higher significance."
    },
    {
      "dataset_filename_table_name_column_name": "negative selection rank",
      "interpretation": "The rank of each gene based on the negative selection score. Lower ranks indicate higher negative selection."
    }
  ]
}
{
  "article_title": "A Genome-Scale CRISPR/Cas9 Knockout Screening Reveals SH3D21 as a Sensitizer for Gemcitabine",
  "dataset_filename": "downloads/masoudiGenomescaleCRISPRCas92019_31844142_41598_2019_55893_MOESM3_ESM.xlsx",
  "sheet_name": "Sheet1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol or identifier"
    },
    {
      "dataset_filename_table_name_column_name": "# Hairpins",
      "interpretation": "The number of hairpins targeting the gene"
    },
    {
      "dataset_filename_table_name_column_name": "NES",
      "interpretation": "The normalized enrichment score (NES) representing the degree of gene enrichment"
    },
    {
      "dataset_filename_table_name_column_name": "Gene rank",
      "interpretation": "The rank of the gene based on its NES"
    },
    {
      "dataset_filename_table_name_column_name": "p-value",
      "interpretation": "The p-value indicating the significance of the gene's association with gemcitabine sensitivity"
    },
    {
      "dataset_filename_table_name_column_name": "p-value rank",
      "interpretation": "The rank of the gene based on its p-value"
    }
  ]
}
{
  "article_title": "A Genome-Scale CRISPR/Cas9 Knockout Screening Reveals SH3D21 as a Sensitizer for Gemcitabine",
  "dataset_filename": "downloads/masoudiGenomescaleCRISPRCas92019_31844142_41598_2019_55893_MOESM2_ESM.xlsx",
  "sheet_name": "Sheet1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene targeted by the CRISPR/Cas9 knockout"
    },
    {
      "dataset_filename_table_name_column_name": "# Hairpins",
      "interpretation": "The number of hairpins targeting the gene"
    },
    {
      "dataset_filename_table_name_column_name": "NES",
      "interpretation": "The normalized enrichment score (NES) for the gene"
    },
    {
      "dataset_filename_table_name_column_name": "Gene rank",
      "interpretation": "The rank of the gene based on its NES"
    },
    {
      "dataset_filename_table_name_column_name": "p-value",
      "interpretation": "The p-value for the gene's association with gemcitabine sensitivity"
    },
    {
      "dataset_filename_table_name_column_name": "p-value rank",
      "interpretation": "The rank of the gene based on its p-value"
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML",
  "dataset_filename": "downloads/nguyenGenomewideCRISPRCas92022_36111891_BLOODA_ADV-2022-007934-mmc1.xlsx",
  "sheet_name": "Supplemental Table S0",
  "dataset_type": "All genes/guides",
  "metrics": ["score", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S0"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol"
    },
    {
      "dataset_filename_table_name_column_name": "Day4.Etop.Score",
      "interpretation": "The etoposide score at day 4"
    },
    {
      "dataset_filename_table_name_column_name": "Day4.Etop.FDR",
      "interpretation": "The false discovery rate (FDR) of the etoposide score at day 4"
    },
    {
      "dataset_filename_table_name_column_name": "Day4.Ess.Score",
      "interpretation": "The essential score at day 4"
    },
    {
      "dataset_filename_table_name_column_name": "Day4.Ess.FDR",
      "interpretation": "The false discovery rate (FDR) of the essential score at day 4"
    },
    {
      "dataset_filename_table_name_column_name": "Day12.Etop.Score",
      "interpretation": "The etoposide score at day 12"
    },
    {
      "dataset_filename_table_name_column_name": "Day12.Etop.FDR",
      "interpretation": "The false discovery rate (FDR) of the etoposide score at day 12"
    },
    {
      "dataset_filename_table_name_column_name": "Day12.Ess.Score",
      "interpretation": "The essential score at day 12"
    },
    {
      "dataset_filename_table_name_column_name": "Day12.Ess.FDR",
      "interpretation": "The false discovery rate (FDR) of the essential score at day 12"
    },
    {
      "dataset_filename_table_name_column_name": "Day18.Etop.Score",
      "interpretation": "The etoposide score at day 18"
    },
    {
      "dataset_filename_table_name_column_name": "Day18.Etop.FDR",
      "interpretation": "The false discovery rate (FDR) of the etoposide score at day 18"
    },
    {
      "dataset_filename_table_name_column_name": "Day18.Ess.Score",
      "interpretation": "The essential score at day 18"
    },
    {
      "dataset_filename_table_name_column_name": "Day18.Ess.FDR",
      "interpretation": "The false discovery rate (FDR) of the essential score at day 18"
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML",
  "dataset_filename": "downloads/nguyenGenomewideCRISPRCas92022_36111891_BLOODA_ADV-2022-007934-mmc1.xlsx",
  "sheet_name": "Supplemental Table S1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S1"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Gene symbol"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "Gene description"
    },
    {
      "dataset_filename_table_name_column_name": "Etop.Score",
      "interpretation": "Etoposide score"
    },
    {
      "dataset_filename_table_name_column_name": "FDR",
      "interpretation": "False discovery rate (FDR)"
    },
    {
      "dataset_filename_table_name_column_name": "Etoposide",
      "interpretation": "Etoposide sensitivity/resistance"
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML",
  "dataset_filename": "downloads/nguyenGenomewideCRISPRCas92022_36111891_BLOODA_ADV-2022-007934-mmc1.xlsx",
  "sheet_name": "Supplemental Table S2",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S2"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Gene symbol"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "Gene description"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "Etoposide response (Sensitive/Resistance)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 4",
      "interpretation": "Time point (Day 4)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 5",
      "interpretation": "Etoposide response score (Day 4)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 6",
      "interpretation": "Etoposide response FDR (Day 4)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 7",
      "interpretation": "Essentiality score (Day 4)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 8",
      "interpretation": "Etoposide response score (Day 12)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 9",
      "interpretation": "Etoposide response FDR (Day 12)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 10",
      "interpretation": "Essentiality score (Day 12)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 11",
      "interpretation": "Etoposide response score (Day 18)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 12",
      "interpretation": "Etoposide response FDR (Day 18)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 13",
      "interpretation": "Essentiality score (Day 18)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 14",
      "interpretation": "[unclear]"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 15",
      "interpretation": "[unclear]"
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML",
  "dataset_filename": "downloads/nguyenGenomewideCRISPRCas92022_36111891_BLOODA_ADV-2022-007934-mmc1.xlsx",
  "sheet_name": "Supplemental Table S3",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Functional pathway enrichment"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Cluster",
      "interpretation": "The cluster of genes/guides associated with etoposide response."
    },
    {
      "dataset_filename_table_name_column_name": "Etoposide",
      "interpretation": "The type of etoposide response (e.g., resistance or sensitivity)."
    },
    {
      "dataset_filename_table_name_column_name": "Ontology",
      "interpretation": "The ontology category of the functional pathway."
    },
    {
      "dataset_filename_table_name_column_name": "Term ID",
      "interpretation": "The ID of the specific term within the ontology category."
    },
    {
      "dataset_filename_table_name_column_name": "Description",
      "interpretation": "The description of the functional pathway."
    },
    {
      "dataset_filename_table_name_column_name": "GeneRatio",
      "interpretation": "The ratio of genes/guides associated with the functional pathway."
    },
    {
      "dataset_filename_table_name_column_name": "BgRatio",
      "interpretation": "The ratio of background genes/guides associated with the functional pathway."
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "The p-value of the functional pathway enrichment."
    },
    {
      "dataset_filename_table_name_column_name": "p.adjust",
      "interpretation": "The adjusted p-value of the functional pathway enrichment."
    },
    {
      "dataset_filename_table_name_column_name": "qvalue",
      "interpretation": "The q-value of the functional pathway enrichment."
    },
    {
      "dataset_filename_table_name_column_name": "Count",
      "interpretation": "The count of genes/guides associated with the functional pathway."
    },
    {
      "dataset_filename_table_name_column_name": "geneID",
      "interpretation": "The gene/guide IDs associated with the functional pathway."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML",
  "dataset_filename": "downloads/nguyenGenomewideCRISPRCas92022_36111891_BLOODA_ADV-2022-007934-mmc1.xlsx",
  "sheet_name": "Supplemental Table S4",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S4"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Ontology Category",
      "interpretation": "The category of the gene ontology (GO) term."
    },
    {
      "dataset_filename_table_name_column_name": "Term name",
      "interpretation": "The name of the GO term."
    },
    {
      "dataset_filename_table_name_column_name": "Description",
      "interpretation": "The description of the GO term."
    },
    {
      "dataset_filename_table_name_column_name": "FDR value",
      "interpretation": "The false discovery rate (FDR) value associated with the GO term."
    },
    {
      "dataset_filename_table_name_column_name": "genes",
      "interpretation": "The genes associated with the GO term."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML",
  "dataset_filename": "downloads/nguyenGenomewideCRISPRCas92022_36111891_BLOODA_ADV-2022-007934-mmc1.xlsx",
  "sheet_name": "Supplemental Table S5",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S5"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Age, Median (Range)",
      "interpretation": "The median age of the pediatric patients in the AML02 cohort is 9.3 years, with a range from 0.0 to 21.2 years."
    },
    {
      "dataset_filename_table_name_column_name": "Sex, n/N (%)",
      "interpretation": "Out of the 163 pediatric patients, 74 (45%) are female and 89 (55%) are male."
    },
    {
      "dataset_filename_table_name_column_name": "Race, n/N (%)",
      "interpretation": "The racial distribution of the pediatric patients in the AML02 cohort is as follows: 31 (19%) are Black, 16 (9.9%) are of other races, and 115 (71%) are White."
    },
    {
      "dataset_filename_table_name_column_name": "Risk Group, n/N (%)",
      "interpretation": "In terms of risk group classification, 43 (26%) pediatric patients are classified as high risk, 55 (34%) as low risk, and 65 (40%) as standard risk."
    },
    {
      "dataset_filename_table_name_column_name": "FLT3 Status, n/N (%)",
      "interpretation": "Regarding FLT3 status, 25 (15%) pediatric patients have FLT3-ITD mutation, 8 (4.9%) have FLT3 mutation, and 129 (80%) have wild type FLT3."
    },
    {
      "dataset_filename_table_name_column_name": "WBC(10^9/L), Median (Range)",
      "interpretation": "The median white blood cell count (WBC) for the pediatric patients in the AML02 cohort is 23 (10^9/L), with a range from 0 to 514 (10^9/L)."
    },
    {
      "dataset_filename_table_name_column_name": "Event, n/N (%)",
      "interpretation": "Out of the 163 pediatric patients, 65 (40%) experienced an event."
    },
    {
      "dataset_filename_table_name_column_name": "Death, n/N (%)",
      "interpretation": "Among the pediatric patients, 47 (29%) died."
    },
    {
      "dataset_filename_table_name_column_name": "MRD1 Positive, n/N (%)",
      "interpretation": "62 (40%) of the 155 pediatric patients tested positive for MRD1."
    },
    {
      "dataset_filename_table_name_column_name": "Risk of Relapsed, n/N (%)",
      "interpretation": "[unclear] The risk of relapse information is not provided in the dataset."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML",
  "dataset_filename": "downloads/nguyenGenomewideCRISPRCas92022_36111891_BLOODA_ADV-2022-007934-mmc1.xlsx",
  "sheet_name": "Supplemental Table S6",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S6"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Common Forward Primer",
      "interpretation": "The common forward primer sequence used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Common Forward Primer sequence",
      "interpretation": "The sequence of the common forward primer used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Index Primer (Reverse) name",
      "interpretation": "The name of the index primer (reverse) used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Index Primer (Reverse) sequence",
      "interpretation": "The sequence of the index primer (reverse) used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Barcode",
      "interpretation": "The barcode sequence associated with the index primer (reverse)."
    },
    {
      "dataset_filename_table_name_column_name": "Reverse-Complement Barcode",
      "interpretation": "The reverse complement sequence of the barcode."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML",
  "dataset_filename": "downloads/nguyenGenomewideCRISPRCas92022_36111891_BLOODA_ADV-2022-007934-mmc1.xlsx",
  "sheet_name": "Supplemental Table S7",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S7"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol of the target gene for the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Target Sequence",
      "interpretation": "The target sequence of the Accell SMARTpool Human siRNA used in the experiments."
    },
    {
      "dataset_filename_table_name_column_name": "TaqMan Gene\nExpression Probe IDs",
      "interpretation": "The TaqMan Gene Expression Probe IDs for the corresponding gene."
    }
  ]
}
{
  "article_title": "Mutational and Functional Genetics Mapping of Chemotherapy Resistance Mechanisms in Relapsed Acute Lymphoblastic Leukemia",
  "dataset_filename": "downloads/oshimaMutationalFunctionalGenetics2020_33796864_NIHMS1673078-supplement-Supplementary_Table_7.xlsx",
  "sheet_name": "Sheet7",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplementary Table 7: CRISPR screen gene-drug interactions in REH ALL cells"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "NaN",
      "interpretation": "Empty row"
    },
    {
      "dataset_filename_table_name_column_name": "Data for 7 genome wide CRISPR screens is reported in separate tabs",
      "interpretation": "Information about the dataset structure"
    }
  ]
}
{
  "article_title": "Mutational and Functional Genetics Mapping of Chemotherapy Resistance Mechanisms in Relapsed Acute Lymphoblastic Leukemia",
  "dataset_filename": "downloads/oshimaMutationalFunctionalGenetics2020_33796864_NIHMS1673078-supplement-Supplementary_Table_7.xlsx",
  "sheet_name": "Vincristine",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Vincristine"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of good sgRNAs for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change for the positive control"
    }
  ]
}
{
  "article_title": "Mutational and Functional Genetics Mapping of Chemotherapy Resistance Mechanisms in Relapsed Acute Lymphoblastic Leukemia",
  "dataset_filename": "downloads/oshimaMutationalFunctionalGenetics2020_33796864_NIHMS1673078-supplement-Supplementary_Table_7.xlsx",
  "sheet_name": "6MP",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["6MP"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the gene or sgRNA in terms of effect on resistance to 6MP in the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of 'good' sgRNAs for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene or sgRNA in terms of effect on resistance to 6MP in the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of 'good' sgRNAs for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change for the positive control"
    }
  ]
}
{
  "article_title": "Mutational and Functional Genetics Mapping of Chemotherapy Resistance Mechanisms in Relapsed Acute Lymphoblastic Leukemia",
  "dataset_filename": "downloads/oshimaMutationalFunctionalGenetics2020_33796864_NIHMS1673078-supplement-Supplementary_Table_7.xlsx",
  "sheet_name": "L-asparaginase",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["L-asparaginase"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier."
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates for the gene or sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of 'good' sgRNAs for the gene in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the gene or sgRNA in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the gene or sgRNA in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the gene or sgRNA in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene or sgRNA in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of 'good' sgRNAs for the gene in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change for the gene or sgRNA in the positive control condition."
    }
  ]
}
{
  "article_title": "Mutational and Functional Genetics Mapping of Chemotherapy Resistance Mechanisms in Relapsed Acute Lymphoblastic Leukemia",
  "dataset_filename": "downloads/oshimaMutationalFunctionalGenetics2020_33796864_NIHMS1673078-supplement-Supplementary_Table_7.xlsx",
  "sheet_name": "AraC",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["AraC"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier."
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates for the gene or sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of good sgRNAs for the gene in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change for the gene or sgRNA in the negative control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the gene or sgRNA in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the gene or sgRNA in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the gene or sgRNA in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene or sgRNA in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs for the gene in the positive control condition."
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change for the gene or sgRNA in the positive control condition."
    }
  ]
}
{
  "article_title": "Mutational and Functional Genetics Mapping of Chemotherapy Resistance Mechanisms in Relapsed Acute Lymphoblastic Leukemia",
  "dataset_filename": "downloads/oshimaMutationalFunctionalGenetics2020_33796864_NIHMS1673078-supplement-Supplementary_Table_7.xlsx",
  "sheet_name": "Methotrexate",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Methotrexate"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of good sgRNAs for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change for the positive control"
    }
  ]
}
{
  "article_title": "Mutational and Functional Genetics Mapping of Chemotherapy Resistance Mechanisms in Relapsed Acute Lymphoblastic Leukemia",
  "dataset_filename": "downloads/oshimaMutationalFunctionalGenetics2020_33796864_NIHMS1673078-supplement-Supplementary_Table_7.xlsx",
  "sheet_name": "Daunorubicin",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Daunorubicin"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of good sgRNAs for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change for the positive control"
    }
  ]
}
{
  "article_title": "Mutational and Functional Genetics Mapping of Chemotherapy Resistance Mechanisms in Relapsed Acute Lymphoblastic Leukemia",
  "dataset_filename": "downloads/oshimaMutationalFunctionalGenetics2020_33796864_NIHMS1673078-supplement-Supplementary_Table_7.xlsx",
  "sheet_name": "Maphosphamide",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Maphosphamide"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of good sgRNAs for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change for the negative control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs for the positive control"
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change for the positive control"
    }
  ]
}
{
  "article_title": "Pooled CRISPR Screening in Pancreatic Cancer Cells Implicates Co-Repressor Complexes as a Cause of Multiple Drug Resistance via Regulation of Epithelial-to-Mesenchymal Transition",
  "dataset_filename": "downloads/ramakerPooledCRISPRScreening2021_34049503_12885_2021_8388_MOESM1_ESM.xlsx",
  "sheet_name": "Sheet1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Tables for Ramaker et al."],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Supplemental Tables for Ramaker et al.",
      "interpretation": "Table containing supplemental information for the study."
    },
    {
      "dataset_filename_table_name_column_name": "Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition",
      "interpretation": "Title of the study."
    },
    {
      "dataset_filename_table_name_column_name": "Author list:",
      "interpretation": "List of authors of the study."
    },
    {
      "dataset_filename_table_name_column_name": "List of Tables:",
      "interpretation": "List of tables available in the dataset."
    },
    {
      "dataset_filename_table_name_column_name": "Supplemental Table S1 Primer Sequences for sgRNA Library Construction",
      "interpretation": "Table containing primer sequences for sgRNA library construction."
    },
    {
      "dataset_filename_table_name_column_name": "Supplemental Table S2 sgRNA sequences for CRISPRact of individual genes and controls",
      "interpretation": "Table containing sgRNA sequences for CRISPR activation (CRISPRact) of individual genes and controls."
    },
    {
      "dataset_filename_table_name_column_name": "Supplemental Table S3A. Activation (SAM) Screen results. L2FC Sum for individual drug-cell line combinations and combined",
      "interpretation": "Table containing activation (SAM) screen results, including log2 fold change (L2FC) sum for individual drug-cell line combinations and combined."
    },
    {
      "dataset_filename_table_name_column_name": "Supplemental Table S3B. Knockout (Gecko) Screen results. L2FC Sum for individual drug-cell line combinations",
      "interpretation": "Table containing knockout (Gecko) screen results, including log2 fold change (L2FC) sum for individual drug-cell line combinations."
    },
    {
      "dataset_filename_table_name_column_name": "Supplemental Table S4A. Top 10 hits for each drug in each cell line for knockout (GecKO) Screen",
      "interpretation": "Table containing top 10 hits for each drug in each cell line for knockout (GecKO) screen."
    },
    {
      "dataset_filename_table_name_column_name": "Supplemental Table S4B. Top 10 hits for each drug in each cell line for Activation (SAM) Screen",
      "interpretation": "Table containing top 10 hits for each drug in each cell line for activation (SAM) screen."
    },
    {
      "dataset_filename_table_name_column_name": "Supplemental Table S5. Results of pathway analysis and Survival p-values used to make Figure 2A",
      "interpretation": "Table containing results of pathway analysis and survival p-values used to make Figure 2A."
    }
  ]
}
{
  "article_title": "Pooled CRISPR Screening in Pancreatic Cancer Cells Implicates Co-Repressor Complexes as a Cause of Multiple Drug Resistance via Regulation of Epithelial-to-Mesenchymal Transition",
  "dataset_filename": "downloads/ramakerPooledCRISPRScreening2021_34049503_12885_2021_8388_MOESM1_ESM.xlsx",
  "sheet_name": "TableS1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["TableS1"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Supplemental Table S1 Primer Sequences for sgRNA Library Construction",
      "interpretation": "Primer sequences used for sgRNA library construction."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Unclear"
    }
  ]
}
{
  "article_title": "Pooled CRISPR Screening in Pancreatic Cancer Cells Implicates Co-Repressor Complexes as a Cause of Multiple Drug Resistance via Regulation of Epithelial-to-Mesenchymal Transition",
  "dataset_filename": "downloads/ramakerPooledCRISPRScreening2021_34049503_12885_2021_8388_MOESM1_ESM.xlsx",
  "sheet_name": "TableS2",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S2 sgRNA sequences for CRISPRact of individual genes and controls"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Guide Name",
      "interpretation": "The name of the guide RNA used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Guide Sequence",
      "interpretation": "The sequence of the guide RNA used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "System tested",
      "interpretation": "The system (e.g., SAM) used for the CRISPR screen."
    }
  ]
}
{
  "article_title": "Pooled CRISPR Screening in Pancreatic Cancer Cells Implicates Co-Repressor Complexes as a Cause of Multiple Drug Resistance via Regulation of Epithelial-to-Mesenchymal Transition",
  "dataset_filename": "downloads/ramakerPooledCRISPRScreening2021_34049503_12885_2021_8388_MOESM1_ESM.xlsx",
  "sheet_name": "TableS3A",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S3A"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene_ID",
      "interpretation": "The unique identifier of a gene."
    },
    {
      "dataset_filename_table_name_column_name": "Combined_L2FC_Sum",
      "interpretation": "The combined log2 fold change (L2FC) sum for individual drug-cell line combinations. It represents the overall effect of gene activation or knockout on drug resistance."
    },
    {
      "dataset_filename_table_name_column_name": "Combined_P",
      "interpretation": "The p-value associated with the combined log2 fold change (L2FC) sum. It indicates the statistical significance of the observed effect."
    },
    {
      "dataset_filename_table_name_column_name": "Combined_FDR",
      "interpretation": "The false discovery rate (FDR) associated with the combined log2 fold change (L2FC) sum. It corrects for multiple hypothesis testing and helps identify significant findings."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Gemcitabine_L2FC_Sum",
      "interpretation": "The log2 fold change (L2FC) sum for gene activation or knockout specifically in response to gemcitabine treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Gemcitabine_P",
      "interpretation": "The p-value associated with the log2 fold change (L2FC) sum for gemcitabine treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Gemcitabine_FDR",
      "interpretation": "The false discovery rate (FDR) associated with the log2 fold change (L2FC) sum for gemcitabine treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Irinotecan_L2FC_Sum",
      "interpretation": "The log2 fold change (L2FC) sum for gene activation or knockout specifically in response to irinotecan treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Irinotecan_P",
      "interpretation": "The p-value associated with the log2 fold change (L2FC) sum for irinotecan treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Irinotecan_FDR",
      "interpretation": "The false discovery rate (FDR) associated with the log2 fold change (L2FC) sum for irinotecan treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Oxaliplatin_L2FC_Sum",
      "interpretation": "The log2 fold change (L2FC) sum for gene activation or knockout specifically in response to oxaliplatin treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Oxaliplatin_P",
      "interpretation": "The p-value associated with the log2 fold change (L2FC) sum for oxaliplatin treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Oxaliplatin_FDR",
      "interpretation": "The false discovery rate (FDR) associated with the log2 fold change (L2FC) sum for oxaliplatin treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_5FU_L2FC_Sum",
      "interpretation": "The log2 fold change (L2FC) sum for gene activation or knockout specifically in response to 5-fluorouracil treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_5FU_P",
      "interpretation": "The p-value associated with the log2 fold change (L2FC) sum for 5-fluorouracil treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_5FU_FDR",
      "interpretation": "The false discovery rate (FDR) associated with the log2 fold change (L2FC) sum for 5-fluorouracil treatment in the Panc-1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Gemcitabine_L2FC_Sum",
      "interpretation": "The log2 fold change (L2FC) sum for gene activation or knockout specifically in response to gemcitabine treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Gemcitabine_P",
      "interpretation": "The p-value associated with the log2 fold change (L2FC) sum for gemcitabine treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Gemcitabine_FDR",
      "interpretation": "The false discovery rate (FDR) associated with the log2 fold change (L2FC) sum for gemcitabine treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Irinotecan_L2FC_Sum",
      "interpretation": "The log2 fold change (L2FC) sum for gene activation or knockout specifically in response to irinotecan treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Irinotecan_P",
      "interpretation": "The p-value associated with the log2 fold change (L2FC) sum for irinotecan treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Irinotecan_FDR",
      "interpretation": "The false discovery rate (FDR) associated with the log2 fold change (L2FC) sum for irinotecan treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Oxaliplatin_L2FC_Sum",
      "interpretation": "The log2 fold change (L2FC) sum for gene activation or knockout specifically in response to oxaliplatin treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Oxaliplatin_P",
      "interpretation": "The p-value associated with the log2 fold change (L2FC) sum for oxaliplatin treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Oxaliplatin_FDR",
      "interpretation": "The false discovery rate (FDR) associated with the log2 fold change (L2FC) sum for oxaliplatin treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_5FU_L2FC_Sum",
      "interpretation": "The log2 fold change (L2FC) sum for gene activation or knockout specifically in response to 5-fluorouracil treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_5FU_P",
      "interpretation": "The p-value associated with the log2 fold change (L2FC) sum for 5-fluorouracil treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_5FU_FDR",
      "interpretation": "The false discovery rate (FDR) associated with the log2 fold change (L2FC) sum for 5-fluorouracil treatment in the BxPC3 cell line."
    }
  ]
}
{
  "article_title": "Pooled CRISPR Screening in Pancreatic Cancer Cells Implicates Co-Repressor Complexes as a Cause of Multiple Drug Resistance via Regulation of Epithelial-to-Mesenchymal Transition",
  "dataset_filename": "downloads/ramakerPooledCRISPRScreening2021_34049503_12885_2021_8388_MOESM1_ESM.xlsx",
  "sheet_name": "TableS3B",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S3B"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Combined_L2FC_Sum",
      "interpretation": "The log2 fold change sum of gene knockout effects across all drug-cell line combinations."
    },
    {
      "dataset_filename_table_name_column_name": "Combined_P",
      "interpretation": "The p-value for the combined effect of gene knockout on drug resistance across all drug-cell line combinations."
    },
    {
      "dataset_filename_table_name_column_name": "Combined_FDR",
      "interpretation": "The false discovery rate (FDR) adjusted p-value for the combined effect of gene knockout on drug resistance across all drug-cell line combinations."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Gemcitabine_L2FC_Sum",
      "interpretation": "The log2 fold change sum of gene knockout effects specifically in response to gemcitabine treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Gemcitabine_P",
      "interpretation": "The p-value for the effect of gene knockout specifically in response to gemcitabine treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Gemcitabine_FDR",
      "interpretation": "The FDR adjusted p-value for the effect of gene knockout specifically in response to gemcitabine treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Oxaliplatin_L2FC_Sum",
      "interpretation": "The log2 fold change sum of gene knockout effects specifically in response to oxaliplatin treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Oxaliplatin_P",
      "interpretation": "The p-value for the effect of gene knockout specifically in response to oxaliplatin treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Oxaliplatin_FDR",
      "interpretation": "The FDR adjusted p-value for the effect of gene knockout specifically in response to oxaliplatin treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Irinotecan_L2FC_Sum",
      "interpretation": "The log2 fold change sum of gene knockout effects specifically in response to irinotecan treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Irinotecan_P",
      "interpretation": "The p-value for the effect of gene knockout specifically in response to irinotecan treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_Irinotecan_FDR",
      "interpretation": "The FDR adjusted p-value for the effect of gene knockout specifically in response to irinotecan treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_5FU_L2FC_Sum",
      "interpretation": "The log2 fold change sum of gene knockout effects specifically in response to 5-fluorouracil treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_5FU_P",
      "interpretation": "The p-value for the effect of gene knockout specifically in response to 5-fluorouracil treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "P1_5FU_FDR",
      "interpretation": "The FDR adjusted p-value for the effect of gene knockout specifically in response to 5-fluorouracil treatment in the Panc1 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Gemcitabine_L2FC_Sum",
      "interpretation": "The log2 fold change sum of gene knockout effects specifically in response to gemcitabine treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Gemcitabine_P",
      "interpretation": "The p-value for the effect of gene knockout specifically in response to gemcitabine treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Gemcitabine_FDR",
      "interpretation": "The FDR adjusted p-value for the effect of gene knockout specifically in response to gemcitabine treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Oxaliplatin_L2FC_Sum",
      "interpretation": "The log2 fold change sum of gene knockout effects specifically in response to oxaliplatin treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Oxaliplatin_P",
      "interpretation": "The p-value for the effect of gene knockout specifically in response to oxaliplatin treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Oxaliplatin_FDR",
      "interpretation": "The FDR adjusted p-value for the effect of gene knockout specifically in response to oxaliplatin treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Irinotecan_L2FC_Sum",
      "interpretation": "The log2 fold change sum of gene knockout effects specifically in response to irinotecan treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Irinotecan_P",
      "interpretation": "The p-value for the effect of gene knockout specifically in response to irinotecan treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_Irinotecan_FDR",
      "interpretation": "The FDR adjusted p-value for the effect of gene knockout specifically in response to irinotecan treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_5FU_L2FC_Sum",
      "interpretation": "The log2 fold change sum of gene knockout effects specifically in response to 5-fluorouracil treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_5FU_P",
      "interpretation": "The p-value for the effect of gene knockout specifically in response to 5-fluorouracil treatment in the BxPC3 cell line."
    },
    {
      "dataset_filename_table_name_column_name": "B3_5FU_FDR",
      "interpretation": "The FDR adjusted p-value for the effect of gene knockout specifically in response to 5-fluorouracil treatment in the BxPC3 cell line."
    }
  ]
}
{
  "article_title": "Pooled CRISPR Screening in Pancreatic Cancer Cells Implicates Co-Repressor Complexes as a Cause of Multiple Drug Resistance via Regulation of Epithelial-to-Mesenchymal Transition",
  "dataset_filename": "downloads/ramakerPooledCRISPRScreening2021_34049503_12885_2021_8388_MOESM1_ESM.xlsx",
  "sheet_name": "Table S4A",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S4A"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Cell line"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "Drug"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "L2FC Sum of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 4",
      "interpretation": "Drug"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 5",
      "interpretation": "L2FC Sum of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 6",
      "interpretation": "Drug"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 7",
      "interpretation": "L2FC Sum of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 8",
      "interpretation": "Drug"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 9",
      "interpretation": "L2FC Sum of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 10",
      "interpretation": "Drug"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 11",
      "interpretation": "L2FC Sum of replicates"
    }
  ]
}
{
  "article_title": "Pooled CRISPR Screening in Pancreatic Cancer Cells Implicates Co-Repressor Complexes as a Cause of Multiple Drug Resistance via Regulation of Epithelial-to-Mesenchymal Transition",
  "dataset_filename": "downloads/ramakerPooledCRISPRScreening2021_34049503_12885_2021_8388_MOESM1_ESM.xlsx",
  "sheet_name": "Table S4B",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S4B"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Cell line"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "Drug"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "Log2 fold change (Sum of replicates)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 4",
      "interpretation": "Cell line"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 5",
      "interpretation": "Drug"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 6",
      "interpretation": "Log2 fold change (Sum of replicates)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 7",
      "interpretation": "Cell line"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 8",
      "interpretation": "Drug"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 9",
      "interpretation": "Log2 fold change (Sum of replicates)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 10",
      "interpretation": "Cell line"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 11",
      "interpretation": "Drug"
    }
  ]
}
{
  "article_title": "Pooled CRISPR Screening in Pancreatic Cancer Cells Implicates Co-Repressor Complexes as a Cause of Multiple Drug Resistance via Regulation of Epithelial-to-Mesenchymal Transition",
  "dataset_filename": "downloads/ramakerPooledCRISPRScreening2021_34049503_12885_2021_8388_MOESM1_ESM.xlsx",
  "sheet_name": "TableS5",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Supplemental Table S5"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Pathway name"
    },
    {
      "dataset_filename_table_name_column_name": "GECKO_log10P",
      "interpretation": "Log10 P-value from GECKO CRISPR screen"
    },
    {
      "dataset_filename_table_name_column_name": "SAM_log10P",
      "interpretation": "Log10 P-value from SAM CRISPR screen"
    },
    {
      "dataset_filename_table_name_column_name": "TCGA_SurvP",
      "interpretation": "Survival P-value from TCGA data"
    }
  ]
}
{
  "article_title": "Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries",
  "dataset_filename": "downloads/ribeiroreilyrochaRevealingTemozolomideResistance2020_33271924_cells-09-02573-s001.xlsx",
  "sheet_name": "Table S1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPRko library enriched genes"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene Name",
      "interpretation": "The name of the gene targeted by the CRISPR-Cas9 knockout or activation"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value indicating the significance of the gene's association with TMZ resistance"
    },
    {
      "dataset_filename_table_name_column_name": "pos|FDR",
      "interpretation": "The false discovery rate (FDR) adjusted p-value for the gene's association with TMZ resistance"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene based on its association with TMZ resistance"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs targeting the gene"
    }
  ]
}
{
  "article_title": "Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries",
  "dataset_filename": "downloads/ribeiroreilyrochaRevealingTemozolomideResistance2020_33271924_cells-09-02573-s001.xlsx",
  "sheet_name": "Table S2 ",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPRa library enriched genes"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene Name",
      "interpretation": "The name of the gene targeted by the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value indicating the significance of the gene's association with TMZ resistance."
    },
    {
      "dataset_filename_table_name_column_name": "pos|FDR",
      "interpretation": "The false discovery rate (FDR) adjusted p-value indicating the significance of the gene's association with TMZ resistance."
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene based on its association with TMZ resistance."
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs targeting the gene."
    }
  ]
}
{
  "article_title": "Activation of the Integrated Stress Response Is a Vulnerability for Multidrug-resistant FBXW7-deficient Cells",
  "dataset_filename": "downloads/sanchez-burgosActivationIntegratedStress2022_35861150_EMMM-14-e15855-s001.xlsx",
  "sheet_name": "CISPLATIN SCREEN (POOL) ",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CISPLATIN SCREEN (POOL)"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Gene symbol or guide RNA name"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Treatment condition (CISPLATIN)"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "Unclear"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "Unclear"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 4",
      "interpretation": "Gene symbol or guide RNA name"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 5",
      "interpretation": "Number of reads"
    }
  ]
}
{
  "article_title": "Activation of the Integrated Stress Response Is a Vulnerability for Multidrug-resistant FBXW7-deficient Cells",
  "dataset_filename": "downloads/sanchez-burgosActivationIntegratedStress2022_35861150_EMMM-14-e15855-s001.xlsx",
  "sheet_name": "UV SCREEN (POOL) ",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["UV SCREEN (POOL) "],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "This column contains empty values."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "This column contains information about the treatment conditions. In this case, it indicates that the cells were treated with UV-C at a dose of 25 J/m2."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "This column contains empty values."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "This column contains information about the genes or sgRNAs tested in the CRISPR screen."
    }
  ]
}
{
  "article_title": "Activation of the Integrated Stress Response Is a Vulnerability for Multidrug-resistant FBXW7-deficient Cells",
  "dataset_filename": "downloads/sanchez-burgosActivationIntegratedStress2022_35861150_EMMM-14-e15855-s001.xlsx",
  "sheet_name": "UV SCREEN (CLONES) ",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["UV SCREEN (CLONES) "],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Empty column"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Treatment condition: UV-C 25 J/m2"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "Empty column"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "Empty column"
    },
    {
      "dataset_filename_table_name_column_name": "Genes identified",
      "interpretation": "Genes identified in the CRISPR screen"
    },
    {
      "dataset_filename_table_name_column_name": "sgRNA sequence",
      "interpretation": "sgRNA sequences used in the CRISPR screen"
    }
  ]
}
{
  "article_title": "Activation of the Integrated Stress Response Is a Vulnerability for Multidrug-resistant FBXW7-deficient Cells",
  "dataset_filename": "downloads/sanchez-burgosActivationIntegratedStress2022_35861150_EMMM-14-e15855-s001.xlsx",
  "sheet_name": "RIGOSERTIB SCREEN (CLONES) ",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["RIGOSERTIB SCREEN (CLONES)"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "This column appears to be empty and may not contain any useful information."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "This column contains the name 'Rigosertib', which could be the name of a drug or treatment used in the study."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "This column appears to be empty and may not contain any useful information."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "This column appears to be empty and may not contain any useful information."
    },
    {
      "dataset_filename_table_name_column_name": "Clone number",
      "interpretation": "This column contains the clone numbers used in the study."
    },
    {
      "dataset_filename_table_name_column_name": "Genes identified",
      "interpretation": "This column contains the names of the genes identified in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "sgRNA sequence",
      "interpretation": "This column contains the sequences of the sgRNAs used in the CRISPR screen."
    }
  ]
}
{
  "article_title": "Activation of the Integrated Stress Response Is a Vulnerability for Multidrug-resistant FBXW7-deficient Cells",
  "dataset_filename": "downloads/sanchez-burgosActivationIntegratedStress2022_35861150_EMMM-14-e15855-s001.xlsx",
  "sheet_name": "CSCi SCREEN (CLONES) ",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CSCi SCREEN (CLONES) "],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "This column contains empty values and does not provide any useful information."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "This column contains the treatment condition 'CSCi 5M' for the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "This column contains empty values and does not provide any useful information."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "This column contains the gene names or identifiers that were identified in the CRISPR screen."
    }
  ]
}
{
  "article_title": "Activation of the Integrated Stress Response Is a Vulnerability for Multidrug-resistant FBXW7-deficient Cells",
  "dataset_filename": "downloads/sanchez-burgosActivationIntegratedStress2022_35861150_EMMM-14-e15855-s001.xlsx",
  "sheet_name": "CISPLATIN SCREEN (CLONES) ",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CISPLATIN SCREEN (CLONES) "],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "Clone number"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "Treatment"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "Gene identified"
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "sgRNA sequence"
    }
  ]
}
{
  "article_title": "Activation of the Integrated Stress Response Is a Vulnerability for Multidrug-resistant FBXW7-deficient Cells",
  "dataset_filename": "downloads/sanchez-burgosActivationIntegratedStress2022_35861150_EMMM-14-e15855-s001.xlsx",
  "sheet_name": "DAB-III SCREEN (CLONES) ",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["DAB-III SCREEN (CLONES)"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Unnamed: 0",
      "interpretation": "This column contains empty values and does not provide any useful information."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 1",
      "interpretation": "This column contains the treatment condition 'DAB-III 25M' for the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 2",
      "interpretation": "This column contains empty values and does not provide any useful information."
    },
    {
      "dataset_filename_table_name_column_name": "Unnamed: 3",
      "interpretation": "This column contains empty values and does not provide any useful information."
    },
    {
      "dataset_filename_table_name_column_name": "Genes identified",
      "interpretation": "This column contains the genes identified in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "sgRNA sequence",
      "interpretation": "This column contains the sgRNA sequences used in the CRISPR screen."
    }
  ]
}
{
  "article_title": "Activation of the Integrated Stress Response Is a Vulnerability for Multidrug-resistant FBXW7-deficient Cells",
  "dataset_filename": "downloads/sanchez-burgosActivationIntegratedStress2022_35861150_EMMM-14-e15855-s001.xlsx",
  "sheet_name": "KMB7 TIGECYCLINE SCREEN",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["KMB7 TIGECYCLINE SCREEN"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene Symbol",
      "interpretation": "The symbol representing a gene that was perturbed in the screen."
    },
    {
      "dataset_filename_table_name_column_name": "Number of perturbations",
      "interpretation": "The number of times the gene was perturbed in the screen."
    },
    {
      "dataset_filename_table_name_column_name": "Ranks of perturbations",
      "interpretation": "The ranks of the perturbations for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Perturbations",
      "interpretation": "The total number of perturbations for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Most enriched perturbation",
      "interpretation": "The most enriched perturbation for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "STARS Score",
      "interpretation": "The STARS score for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "Average Score",
      "interpretation": "The average score for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "p-value",
      "interpretation": "The p-value for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "FDR",
      "interpretation": "The false discovery rate (FDR) for the gene."
    },
    {
      "dataset_filename_table_name_column_name": "q-value",
      "interpretation": "The q-value for the gene."
    }
  ]
}
{
  "article_title": "Activation of the Integrated Stress Response Is a Vulnerability for Multidrug-resistant FBXW7-deficient Cells",
  "dataset_filename": "downloads/sanchez-burgosActivationIntegratedStress2022_35861150_EMMM-14-e15855-s001.xlsx",
  "sheet_name": "DATASET EV1 LEGEND",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["DATASET EV1"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "DATASET EV1. Raw data from the CRISPR screens shown in this work. This dataset provides the raw data for the various CRISPR-screen shown in our manuscript. The first two tabs indicate the number of reads for sgRNAs targeting the indicated genes found in screenings of mESC treated with either cisplatin or UV at the indicated doses. Pools of treatment resistant cells were isolated and libraries of PCR-amplified sgRNAs were sequenced by Illumina sequencing. The next five tabs provide the sgRNAs that were identified by Sanger sequencing in individual clones of mESC cells that were isolated on the basis of being resistant to the indicated agents. The final tab provides the raw data for the genomewide CRISPR screen conducted in KBM7 cells treated with tigecycline for 11 days. The list is ordered on the basis of enrichment of indidivual genes.",
      "interpretation": "This dataset contains raw data from various CRISPR screens conducted in this study. The first two tabs provide the number of reads for sgRNAs targeting specific genes in screenings of mESC cells treated with either cisplatin or UV at different doses. Pools of treatment-resistant cells were isolated and libraries of PCR-amplified sgRNAs were sequenced using Illumina sequencing. The next five tabs contain the sgRNAs identified by Sanger sequencing in individual clones of mESC cells that were resistant to specific agents. The final tab provides the raw data for a genomewide CRISPR screen conducted in KBM7 cells treated with tigecycline for 11 days. The genes in this tab are ordered based on their enrichment in the screen. [unclear]"
    }
  ]
}
{
  "article_title": "Pseudo-Temporal Dynamics of Chemoresistant Triple Negative Breast Cancer Cells Reveal EGFR/HER2 Inhibition as Synthetic Lethal during Mid-Neoadjuvant Chemotherapy",
  "dataset_filename": "downloads/songPseudotemporalDynamicsChemoresistant2023_36824282_mmc2.xlsx",
  "sheet_name": "Table S1A",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Table S1A"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "z.3VS5.Paclitaxel_VS_T0",
      "interpretation": "Significance of knock-outs in promoting or sensitizing chemo response to Paclitaxel treatment. Positive z-scores (>1.96) indicate chemo-promoting knock-outs, while negative z-scores (<-1.96) indicate chemo-sensitizing knock-outs."
    }
  ]
}
{
  "article_title": "Pseudo-Temporal Dynamics of Chemoresistant Triple Negative Breast Cancer Cells Reveal EGFR/HER2 Inhibition as Synthetic Lethal during Mid-Neoadjuvant Chemotherapy",
  "dataset_filename": "downloads/songPseudotemporalDynamicsChemoresistant2023_36824282_mmc2.xlsx",
  "sheet_name": "Table S1B",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Table S1B"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Table S1B.z.3VS5.Paclitaxel_VS_T0",
      "interpretation": "Significant results from CRISPR-Cas9 knock-out screening for Doxorubucin treatments in MCF10A. Chemo-promoting/-sensitizing knock-outs (z-score > 1.96 or z-score < -1.96) are highlighted by red/blue in column z.3VS5.Paclitaxel_VS_T0."
    }
  ]
}
{
  "article_title": "Pseudo-Temporal Dynamics of Chemoresistant Triple Negative Breast Cancer Cells Reveal EGFR/HER2 Inhibition as Synthetic Lethal during Mid-Neoadjuvant Chemotherapy",
  "dataset_filename": "downloads/songPseudotemporalDynamicsChemoresistant2023_36824282_mmc2.xlsx",
  "sheet_name": "Sheet3",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Sheet3"],
  "col_names_interpretations": []
}
{
  "article_title": "A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer",
  "dataset_filename": "downloads/tianFifteenGeneClassifier2021_34026427_ADVS-8-2001978-s005.xlsx",
  "sheet_name": "all_286_genes",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Gene Expression Data"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol."
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "The average gene expression level across all samples."
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "The log2 fold change in gene expression between the treatment group and the control group."
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "The standard error of the log2 fold change."
    },
    {
      "dataset_filename_table_name_column_name": "stat",
      "interpretation": "The test statistic value for the differential expression of the gene."
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "The p-value for the differential expression of the gene."
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "The adjusted p-value (FDR) for the differential expression of the gene."
    }
  ]
}
{
  "article_title": "A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer",
  "dataset_filename": "downloads/tianFifteenGeneClassifier2021_34026427_ADVS-8-2001978-s005.xlsx",
  "sheet_name": "DDP",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Gene Expression Data"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol"
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "The average gene expression level across all samples"
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "The log2 fold change in gene expression between the treatment group and the control group"
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "The standard error of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "stat",
      "interpretation": "The test statistic value"
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "The p-value of the statistical test"
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "The adjusted p-value (FDR) of the statistical test"
    }
  ]
}
{
  "article_title": "A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer",
  "dataset_filename": "downloads/tianFifteenGeneClassifier2021_34026427_ADVS-8-2001978-s005.xlsx",
  "sheet_name": "DDP_Taxol",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["DDP_Taxol"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol representing a specific gene in the dataset."
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "The average gene expression level across all samples in the dataset."
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "The log2 fold change in gene expression between the treatment group and the control group."
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "The standard error of the log2 fold change."
    },
    {
      "dataset_filename_table_name_column_name": "stat",
      "interpretation": "The statistical test statistic for the differential expression of the gene."
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "The p-value associated with the statistical test for the differential expression of the gene."
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "The adjusted p-value (e.g., FDR-adjusted p-value) associated with the statistical test for the differential expression of the gene."
    }
  ]
}
{
  "article_title": "A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer",
  "dataset_filename": "downloads/tianFifteenGeneClassifier2021_34026427_ADVS-8-2001978-s005.xlsx",
  "sheet_name": "Taxol",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Taxol"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol"
    },
    {
      "dataset_filename_table_name_column_name": "baseMean",
      "interpretation": "The average gene expression level across all samples"
    },
    {
      "dataset_filename_table_name_column_name": "log2FoldChange",
      "interpretation": "The log2 fold change in gene expression between the treatment group and the control group"
    },
    {
      "dataset_filename_table_name_column_name": "lfcSE",
      "interpretation": "The standard error of the log2 fold change"
    },
    {
      "dataset_filename_table_name_column_name": "stat",
      "interpretation": "The test statistic value"
    },
    {
      "dataset_filename_table_name_column_name": "pvalue",
      "interpretation": "The p-value of the statistical test"
    },
    {
      "dataset_filename_table_name_column_name": "padj",
      "interpretation": "The adjusted p-value (e.g., FDR) to account for multiple testing"
    }
  ]
}
{
  "article_title": "Targeted CRISPR Screening Identifies PRMT5 as Synthetic Lethality Combinatorial Target with Gemcitabine in Pancreatic Cancer Cells",
  "dataset_filename": "downloads/weiTargetedCRISPRScreening2020_33097661_pnas.2009899117.sd01.csv",
  "sheet_name": "None",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "sgRNA",
      "interpretation": "The sgRNA used in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene targeted by the sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "cont1",
      "interpretation": "The abundance metric (unclear) for the control condition 1."
    },
    {
      "dataset_filename_table_name_column_name": "cont2",
      "interpretation": "The abundance metric (unclear) for the control condition 2."
    },
    {
      "dataset_filename_table_name_column_name": "cont3",
      "interpretation": "The abundance metric (unclear) for the control condition 3."
    },
    {
      "dataset_filename_table_name_column_name": "gemc1",
      "interpretation": "The abundance metric (unclear) for the gemcitabine-treated condition 1."
    },
    {
      "dataset_filename_table_name_column_name": "gemc2",
      "interpretation": "The abundance metric (unclear) for the gemcitabine-treated condition 2."
    },
    {
      "dataset_filename_table_name_column_name": "gemc3",
      "interpretation": "The abundance metric (unclear) for the gemcitabine-treated condition 3."
    }
  ]
}
{
  "article_title": "Targeted CRISPR Screening Identifies PRMT5 as Synthetic Lethality Combinatorial Target with Gemcitabine in Pancreatic Cancer Cells",
  "dataset_filename": "downloads/weiTargetedCRISPRScreening2020_33097661_pnas.2009899117.sd02.csv",
  "sheet_name": "None",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR screen dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "gene_id",
      "interpretation": "The unique identifier of each gene targeted in the CRISPR screen."
    },
    {
      "dataset_filename_table_name_column_name": "MPANC_CON-DMSO-1_S1",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the MPANC cell line treated with DMSO control."
    },
    {
      "dataset_filename_table_name_column_name": "MPANC_CON-DMSO-2_S2",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the MPANC cell line treated with DMSO control."
    },
    {
      "dataset_filename_table_name_column_name": "MPANC_CON-Gem-1_S3",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the MPANC cell line treated with Gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "MPANC_CON-Gem-2_S4",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the MPANC cell line treated with Gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "MPANC_KO-DMSO-1_S9",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the MPANC cell line with PRMT5 depletion treated with DMSO control."
    },
    {
      "dataset_filename_table_name_column_name": "MPANC_KO-DMSO-2_S10",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the MPANC cell line with PRMT5 depletion treated with DMSO control."
    },
    {
      "dataset_filename_table_name_column_name": "MPANC_KO-Gem-1_S11",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the MPANC cell line with PRMT5 depletion treated with Gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "MPANC_KO-Gem-2_S12",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the MPANC cell line with PRMT5 depletion treated with Gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "PANC1_CON-DMSO-1_S1",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the PANC1 cell line treated with DMSO control."
    },
    {
      "dataset_filename_table_name_column_name": "PANC1_CON-DMSO-2_S2",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the PANC1 cell line treated with DMSO control."
    },
    {
      "dataset_filename_table_name_column_name": "PANC1_CON-Gem-1_S3",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the PANC1 cell line treated with Gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "PANC1_CON-Gem-2_S4",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the PANC1 cell line treated with Gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "PANC1_KO-DMSO-1_S9",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the PANC1 cell line with PRMT5 depletion treated with DMSO control."
    },
    {
      "dataset_filename_table_name_column_name": "PANC1_KO-DMSO-2_S10",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the PANC1 cell line with PRMT5 depletion treated with DMSO control."
    },
    {
      "dataset_filename_table_name_column_name": "PANC1_KO-Gem-1_S11",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the PANC1 cell line with PRMT5 depletion treated with Gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "PANC1_KO-Gem-2_S12",
      "interpretation": "The abundance metric (count, score, fold change, or P-value/FDR) of gene knockout in the PANC1 cell line with PRMT5 depletion treated with Gemcitabine."
    }
  ]
}
{
  "article_title": "CRISPR-based Knockout Screening Identifies the Loss of MIEF2 to Enhance Oxaliplatin Resistance in Colorectal Cancer through Inhibiting the Mitochondrial Apoptosis Pathway",
  "dataset_filename": "downloads/xieCRISPRbasedKnockoutScreening2022_36106106_DataSheet_1.xlsx",
  "sheet_name": "Genelist of OXL",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Genelist of OXL"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Gene",
      "interpretation": "The gene symbol of the target gene."
    },
    {
      "dataset_filename_table_name_column_name": "Baseline",
      "interpretation": "The baseline abundance of the gene or sgRNA."
    },
    {
      "dataset_filename_table_name_column_name": "PBS",
      "interpretation": "The abundance of the gene or sgRNA in the control condition (PBS)."
    },
    {
      "dataset_filename_table_name_column_name": "OX",
      "interpretation": "The abundance of the gene or sgRNA in the oxaliplatin-treated condition."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR Screen Identifies ELP5 as a Determinant of Gemcitabine Sensitivity in Gallbladder Cancer",
  "dataset_filename": "downloads/xuGenomewideCRISPRScreen2019_31792210_41467_2019_13420_MOESM4_ESM.xlsx",
  "sheet_name": "210 gene hits",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Gene Hits"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene symbol or identifier"
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of guides targeting the gene"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score indicating the significance of the gene's effect on gemcitabine sensitivity"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value indicating the significance of the gene's effect on gemcitabine sensitivity"
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) indicating the significance of the gene's effect on gemcitabine sensitivity"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene based on its effect on gemcitabine sensitivity"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs targeting the gene"
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change of gene abundance in gemcitabine-treated cells compared to control cells"
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR Screen Identifies ELP5 as a Determinant of Gemcitabine Sensitivity in Gallbladder Cancer",
  "dataset_filename": "downloads/xuGenomewideCRISPRScreen2019_31792210_41467_2019_13420_MOESM4_ESM.xlsx",
  "sheet_name": "GO analysis",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "Enrichment", "Z-score"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["GO analysis"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Category",
      "interpretation": "The category of the gene ontology term."
    },
    {
      "dataset_filename_table_name_column_name": "GO",
      "interpretation": "The gene ontology term ID."
    },
    {
      "dataset_filename_table_name_column_name": "Description",
      "interpretation": "The description of the gene ontology term."
    },
    {
      "dataset_filename_table_name_column_name": "LogP",
      "interpretation": "The logarithm of the P-value/FDR."
    },
    {
      "dataset_filename_table_name_column_name": "Enrichment",
      "interpretation": "The enrichment score."
    },
    {
      "dataset_filename_table_name_column_name": "Z-score",
      "interpretation": "The Z-score."
    },
    {
      "dataset_filename_table_name_column_name": "GeneID",
      "interpretation": "The gene IDs associated with the gene ontology term."
    },
    {
      "dataset_filename_table_name_column_name": "Hits",
      "interpretation": "The gene symbols associated with the gene ontology term."
    },
    {
      "dataset_filename_table_name_column_name": "Log(q-value)",
      "interpretation": "The logarithm of the q-value."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR Screen Identifies ELP5 as a Determinant of Gemcitabine Sensitivity in Gallbladder Cancer",
  "dataset_filename": "downloads/xuGenomewideCRISPRScreen2019_31792210_41467_2019_13420_MOESM4_ESM.xlsx",
  "sheet_name": "KEGG analysis",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["KEGG analysis"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "Category",
      "interpretation": "The category of the gene set or pathway."
    },
    {
      "dataset_filename_table_name_column_name": "GO",
      "interpretation": "The Gene Ontology (GO) term associated with the gene set or pathway."
    },
    {
      "dataset_filename_table_name_column_name": "Description",
      "interpretation": "A description of the gene set or pathway."
    },
    {
      "dataset_filename_table_name_column_name": "LogP",
      "interpretation": "The logarithm of the P-value or FDR."
    },
    {
      "dataset_filename_table_name_column_name": "Enrichment",
      "interpretation": "The enrichment score."
    },
    {
      "dataset_filename_table_name_column_name": "Z-score",
      "interpretation": "The Z-score."
    },
    {
      "dataset_filename_table_name_column_name": "GeneID",
      "interpretation": "The GeneID(s) associated with the gene set or pathway."
    },
    {
      "dataset_filename_table_name_column_name": "Hits",
      "interpretation": "The gene symbol(s) associated with the gene set or pathway."
    },
    {
      "dataset_filename_table_name_column_name": "Log(q-value)",
      "interpretation": "The logarithm of the q-value."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR Screen Identifies ELP5 as a Determinant of Gemcitabine Sensitivity in Gallbladder Cancer",
  "dataset_filename": "downloads/xuGenomewideCRISPRScreen2019_31792210_41467_2019_13420_MOESM4_ESM.xlsx",
  "sheet_name": "reads out counts",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change", "count"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["CRISPR Screen Dataset"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "GeneID",
      "interpretation": "The unique identifier of a gene."
    },
    {
      "dataset_filename_table_name_column_name": "Survive_1",
      "interpretation": "The number of surviving cells in replicate 1 after treatment with gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "Survive_2",
      "interpretation": "The number of surviving cells in replicate 2 after treatment with gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "Input_1",
      "interpretation": "The number of cells in replicate 1 before treatment with gemcitabine."
    },
    {
      "dataset_filename_table_name_column_name": "Input_2",
      "interpretation": "The number of cells in replicate 2 before treatment with gemcitabine."
    }
  ]
}
{
  "article_title": "Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer",
  "dataset_filename": "downloads/yangGenomeWideCRISPRScreening2022_35804923_cancers-14-03152-s001.xlsx",
  "sheet_name": "Sheet1",
  "dataset_type": "All genes/guides",
  "metrics": ["P-value/FDR", "score", "fold change"],
  "table_multiplicity": "Singular",
  "table_name_or_names": ["Gemcitabine Resistance"],
  "col_names_interpretations": [
    {
      "dataset_filename_table_name_column_name": "id",
      "interpretation": "The gene or sgRNA identifier"
    },
    {
      "dataset_filename_table_name_column_name": "num",
      "interpretation": "The number of replicates"
    },
    {
      "dataset_filename_table_name_column_name": "neg|score",
      "interpretation": "The score of the gene or sgRNA in the negative control condition"
    },
    {
      "dataset_filename_table_name_column_name": "neg|p-value",
      "interpretation": "The p-value of the gene or sgRNA in the negative control condition"
    },
    {
      "dataset_filename_table_name_column_name": "neg|fdr",
      "interpretation": "The false discovery rate (FDR) of the gene or sgRNA in the negative control condition"
    },
    {
      "dataset_filename_table_name_column_name": "neg|rank",
      "interpretation": "The rank of the gene or sgRNA in the negative control condition"
    },
    {
      "dataset_filename_table_name_column_name": "neg|goodsgrna",
      "interpretation": "The number of good sgRNAs for the gene in the negative control condition"
    },
    {
      "dataset_filename_table_name_column_name": "neg|lfc",
      "interpretation": "The log fold change of the gene or sgRNA in the negative control condition"
    },
    {
      "dataset_filename_table_name_column_name": "pos|score",
      "interpretation": "The score of the gene or sgRNA in the positive control condition"
    },
    {
      "dataset_filename_table_name_column_name": "pos|p-value",
      "interpretation": "The p-value of the gene or sgRNA in the positive control condition"
    },
    {
      "dataset_filename_table_name_column_name": "pos|fdr",
      "interpretation": "The false discovery rate (FDR) of the gene or sgRNA in the positive control condition"
    },
    {
      "dataset_filename_table_name_column_name": "pos|rank",
      "interpretation": "The rank of the gene or sgRNA in the positive control condition"
    },
    {
      "dataset_filename_table_name_column_name": "pos|goodsgrna",
      "interpretation": "The number of good sgRNAs for the gene in the positive control condition"
    },
    {
      "dataset_filename_table_name_column_name": "pos|lfc",
      "interpretation": "The log fold change of the gene or sgRNA in the positive control condition"
    }
  ]
}
